http://www.pharmajournalist.com/uks-mhra-grants-early-access-to-sanofis-dermatology-treatment/ 2017-04-12T14:21:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/MHRA.jpg http://www.pharmajournalist.com/pfizer-launches-zavicefta-in-uk-and-germany/ 2017-04-12T14:23:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/pfize.jpg http://www.pharmajournalist.com/arix-bioscience-raises-100m-ipo/ 2017-04-14T09:29:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Arix-Biosciences.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/Arix-Biosciences.jpg http://www.pharmajournalist.com/momenta-announces-fda-warning-letter-contracted-glatopas-fillfinish-manufacturer/ 2017-04-14T09:33:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/takeda-acquires-ariad-pharmaceuticals/ 2017-04-14T09:39:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ariad-logo.jpg http://www.pharmajournalist.com/fda-accepts-intellipharmaceutics-nda-rexista-treat-moderate-severe-pain/ 2017-04-14T09:42:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/genticel-genkyotex-sign-agreement-merge/ 2017-04-14T10:14:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fluor-build-novo-nordisks-2bn-api-manufacturing-facility-north-carolina/ 2017-04-14T10:16:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/mercks-subsidiary-wins-2-5bn-patent-verdict-gilead-sciences/ 2017-04-14T10:21:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/merck-group.jpg http://www.pharmajournalist.com/gsk-open-new-global-vaccines-rd-center-maryland-us/ 2017-04-14T10:25:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/alexion-pharmaceuticals-names-david-brennan-interim-ceo/ 2017-04-14T10:32:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/David-Brennan-Alexion-Pharmaceuticals.jpeg https://pharmajournalist.com/wp-content/uploads/2017/04/David-Brennan-Alexion-Pharmaceuticals.jpeg http://www.pharmajournalist.com/celgene-ibm-watson-develop-new-offering-patient-safety-monitoring/ 2017-04-14T10:45:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/celgene.jpg http://www.pharmajournalist.com/nimbus-secures-200m-gilead-inhibitor-program-acquisition/ 2017-04-14T10:48:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Nimbus-Therapeutics.png http://www.pharmajournalist.com/portola-expands-collaboration-daiichi-develop-andexxa-germany/ 2017-04-14T10:51:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/iv-administered-ganaxolone-diazepam-synergistically-block-seizures-animal-model-se/ 2017-04-14T11:00:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Marinus-Pharmaceuticals.jpg http://www.pharmajournalist.com/sun-pharma-buy-85-stake-russian-pharmaceutical-firm-biosintez/ 2017-04-14T11:04:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/neovacs-partners-3p-biopharmaceuticals-manufacture-interferon-alpha-cytokine/ 2017-04-14T11:10:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/neovac.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-opens-new-clinical-services-facility-south-korea/ 2017-04-14T11:15:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/horizon-discovery-licenses-biomanufacturing-cell-lines-cpi-nibrt/ 2017-04-14T11:20:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/horizon_logo.png http://www.pharmajournalist.com/gsk-names-emma-walmsley-new-ceo/ 2017-04-14T11:29:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Emma-Walmsley.png https://pharmajournalist.com/wp-content/uploads/2017/04/Emma-Walmsley.png http://www.pharmajournalist.com/pharmaron-enters-non-binding-heads-terms-msd-hoddesdon-uk-site/ 2017-04-14T11:38:29+00:00 https://pharmajournalist.com/wp-content/uploads/2016/09/pharmaron.png http://www.pharmajournalist.com/depomed-gets-favorable-patent-ruling-us-nucynta-andas/ 2017-04-14T11:51:43+00:00 https://pharmajournalist.com/wp-content/uploads/2016/10/depomed.jpg http://www.pharmajournalist.com/vbl-therapeutics-unveils-plans-build-new-manufacturing-facility-israel/ 2017-04-14T12:17:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/VBL.png http://www.pharmajournalist.com/virtus-sues-fda-clearing-potassium-chloride-market-competition/ 2017-04-14T12:25:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-accepts-priority-review-bristol-myers-sbla-opdivo-urothelial-carcinoma-use/ 2017-04-14T12:26:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/allergan-sells-global-generics-business-teva-pharmaceuticals/ 2017-04-14T12:35:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Allergan.png http://www.pharmajournalist.com/jj-bayers-xarel-cuts-recurrence-dangerous-blood-clots-study/ 2017-04-15T11:37:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/ptc-therapeutics-announces-agreement-acquire-emflaza-marathon-pharmaceuticals-llc/ 2017-04-15T11:44:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/kadimastem-granted-patent-us-treatment-neurodegenerative-diseases/ 2017-04-15T11:45:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/alkermes-initiates-phase-3-gastrointestinal-tolerability-study-alks-8700/ 2017-04-15T11:46:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/ferring-collaborates-icf-development-potential-new-treatment-anal-fissures/ 2017-04-15T11:49:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/glycyx-pharmaventures-valeant-pharmaceuticals-agree-binding-terms-licensing-agreement-field-oncology/ 2017-04-15T11:50:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/biocept-catalyst-pharmaceuticals-collaborate-provide-liquid-biopsy-testing-small-cell-lung-cancer/ 2017-04-15T11:52:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/pfizer-launches-zavicefta-ceftazidime-avibactam-u-k-germany/ 2017-04-15T12:01:15+00:00 http://www.pharmajournalist.com/amo-pharma-enters-collaboration-agreement-ranedis-pharmaceuticals/ 2017-04-15T12:02:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/neogenomics-definiens-enter-agreement-develop-novel-assays-clinical-trials-clinical-testing/ 2017-04-15T12:03:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/charles-river-laboratories-chiesi-farmaceutici-spa-announce-extension-integrated-respiratory-drug-discovery-program/ 2017-04-15T12:04:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/mylan-announces-global-settlement-license-agreements-genentech-roche-herceptin/ 2017-04-15T12:12:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan.jpg http://www.pharmajournalist.com/midatech-announces-successful-initial-scale-sustained-release-manufacturing-facility/ 2017-04-15T12:13:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/amring-pharmaceuticals-acquired-six-andas/ 2017-04-15T12:18:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amring-pharmaceuticals.jpg http://www.pharmajournalist.com/pharnext-announces-rd-agreement-galapagos/ 2017-04-15T12:21:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/bioreclamationivt-acquires-transcell-science/ 2017-04-15T12:22:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/espero-pharmaceuticals.jpg http://www.pharmajournalist.com/kitov-announces-license-agreement-kit-302-south-korea/ 2017-04-15T12:23:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/abeona-therapeutics-receives-orphan-drug-designation-european-union-eb-101/ 2017-04-15T12:25:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abeona-therapeutics.jpg http://www.pharmajournalist.com/kasten-inc-completes-merger-dakota-life-sciences/ 2017-04-15T12:29:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/glenmark-pharmaceuticals-receives-fda-clearance-ind-gsp-304/ 2017-04-15T12:30:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/nuvox-pharma-university-arkansas-initiate-phase-ibii-clinical-trial-stroke/ 2017-04-15T12:35:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/nuvox-pharma.png http://www.pharmajournalist.com/sanofi-regeneron-say-latest-dupixent-eczema-drug-tests-positive/ 2017-04-15T12:40:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi.jpg http://www.pharmajournalist.com/concert-pharmaceuticals-presents-ctp-543-phase-1-results-american-academy-dermatology-annual-meeting/ 2017-04-15T12:43:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/cardiome-announces-commercial-launch-xydalba-dalbavancin-france/ 2017-04-15T12:45:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/integral-molecular-integrated-biotherapeutics-initiate-collaboration-virus-vaccine-discovery/ 2017-04-15T12:47:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/synthon-biopharmaceuticals-enters-worldwide-exclusive-license-collaboration-sanquin/ 2017-04-15T12:51:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/synthon-logo.jpg http://www.pharmajournalist.com/fda-grants-authorization-abbott-real-time-zika-test-using-whole-blood/ 2017-04-17T12:18:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/kathleen-tregoning-appointed-sanofis-external-affairs-executive-vp/ 2017-04-17T12:42:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Kathleen-Tregoning-sanofi.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/Kathleen-Tregoning-sanofi.jpg http://www.pharmajournalist.com/veeva-rolls-cloud-application-accelerate-regulatory-submission-delivery/ 2017-04-19T05:29:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/arven-selects-ge-healthcares-manufacturing-platform-expand-production-capacity-turkish-facility/ 2017-04-19T05:30:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/ibm-seeks-publics-help-find-new-cancer-cures/ 2017-04-19T05:31:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/lundbeck-ibm-watson-health-partner-neurological-psychiatric-drug-discovery/ 2017-04-19T05:33:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/abzena-signs-licensing-deal-thiobridge-antibody-drug-conjugate-linker-technology/ 2017-04-19T05:35:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/menarini-silicons-deparray-technology-aids-researchers-lung-cancer-study/ 2017-04-19T05:36:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/tillotts-introduces-new-technology-colonic-targeting-active-molecules/ 2017-04-19T05:37:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/parexel-launches-idmp-focused-software-solution-biopharmaceutical-firms/ 2017-04-19T05:38:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/ers-genomics-agrees-license-crisprcas9-knudra-transgenics/ 2017-04-19T05:41:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/jazz-enrolls-first-patient-jzp-110s-phase-2-trial-excessive-sleepiness-pd-patients/ 2017-04-22T10:51:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/gw-pharmaceuticals-cannabis-derived-drug-shows-promise-brain-cancer-trial/ 2017-04-22T10:55:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/GWPharmaceuticalsLogo.jpg http://www.pharmajournalist.com/regenerx-licensee-receives-fda-permission-conduct-phase-3-trial-rgn-137/ 2017-04-24T06:37:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/xynomic-pharma-acquired-worldwide-rights-abexinostat/ 2017-04-24T06:43:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/xynomic-pharma.jpg http://www.pharmajournalist.com/novartis-wins-chmp-nod-drug-combo-lung-cancers/ 2017-04-24T07:03:35+00:00 http://www.pharmajournalist.com/santen-twoxar-announce-strategic-research-collaboration-discover-new-glaucoma-treatments/ 2017-04-24T07:04:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/cyclacels-leukemia-drug-elderly-patients-fails-key-study/ 2017-04-24T07:07:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/soligenix-receives-european-patent-formulation-synthetic-hypericin-treat-psoriasis/ 2017-04-24T07:09:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/valeant-pharmaceuticals-eyegate-enter-licensing-agreement-egp-437-combination-product/ 2017-04-24T07:12:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/fda-rejects-amphastars-nasal-opioid-overdose-treatment/ 2017-04-24T07:14:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/icon-selected-fda-validate-patient-reported-outcome-endpoints-antibacterial-drug-trials/ 2017-04-24T07:15:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/xbrane-biopharma-obtains-gmp-certification-spherotide-production-facility/ 2017-04-24T07:20:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/xbrane-pharma.png http://www.pharmajournalist.com/immune-pharmaceuticals-announces-launch-remain/ 2017-04-24T07:22:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/ctt-pharmaceutical-holdings-cannimed-therapeutics-inc-complete-exclusive-canadian-licensing-agreement/ 2017-04-24T07:25:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/cannimed.png http://www.pharmajournalist.com/catalent-completes-accucaps-acquisition/ 2017-04-25T06:22:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Catelent-Office.png http://www.pharmajournalist.com/uniqure-announces-fda-breakthrough-therapy-designation-amt-060-hemophilia-b/ 2017-04-25T07:06:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/uniqure.jpg http://www.pharmajournalist.com/uniqure-appoints-alexander-kuta-senior-vice-president-regulatory-affairs/ 2017-04-25T07:09:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dr-alex-kuta-uniqure.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/dr-alex-kuta-uniqure.jpg http://www.pharmajournalist.com/uniqure-appoints-matthew-kapusta-chief-executive-officer/ 2017-04-25T07:12:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/CEO-Matthew-Kapusta.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/04/CEO-Matthew-Kapusta.jpg http://www.pharmajournalist.com/health-canada-approves-otsuka-lundbecks-rexulti/ 2017-04-25T07:19:15+00:00 http://www.pharmajournalist.com/imprimis-pharmaceuticals-begins-dispensing-fda-registered-503b-outsourcing-facility/ 2017-04-25T07:21:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/dauntless-pharmaceuticals-announces-initiation-phase-1-clinical-trial-octreotide-formulation-intranasal-delivery/ 2017-04-25T07:23:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/x-chem-expands-collaboration-janssen-inflammatory-diseases/ 2017-04-25T07:31:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/mayne-pharma-launches-butalbital-acetaminophen-tablets-united-states/ 2017-04-25T07:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mayne-pharma.jpg http://www.pharmajournalist.com/solasia-lees-pharma-announce-license-promotion-supply-agreement-episil/ 2017-04-25T07:51:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/fda-takes-action-14-companies-selling-illegal-cancer-treatments/ 2017-04-28T15:12:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/amri-announces-strategic-alliance-advance-mass-spectrometry-capabilities-drug-discovery/ 2017-04-29T12:09:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/fda-approves-amgens-parsabiv-etelcalcetide-secondary-hyperparathyroidism/ 2017-04-29T12:11:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/vyome-biosciences-announces-top-line-results-phase-1-study-vb-1953/ 2017-04-29T12:13:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/strata-oncology-announces-collaboration-epizyme-support-tazemetostat-clinical-development/ 2017-04-29T12:16:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/strata-oncology-logo.jpg http://www.pharmajournalist.com/aura-biosciences-receives-fda-clearance-investigational-new-drug-application-light-activated-au-011-treatment-ocular-melanoma/ 2017-04-29T12:17:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/quotient-clinical-expands-usa-acquisition-seaview-research-specialist-clinical-pharmacology-business/ 2017-04-29T12:20:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/quotient-clinical.jpeg http://www.pharmajournalist.com/cocoon-biotech-announces-partnership-camargo-pharmaceutical-services-development-programs/ 2017-04-29T12:24:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/cocoon-biotech-inc-logo.png http://www.pharmajournalist.com/lysogene-receives-orphan-drug-designation-fda-lys-gm101/ 2017-04-29T12:25:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/teva-confirms-generic-victoza-patent-challenge-united-states/ 2017-04-29T12:27:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/TEVA-Pharma.jpg http://www.pharmajournalist.com/meridian-lab-apobiologix-enter-definitive-agreement-docetaxel-injection/ 2017-04-29T12:31:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/meridian-lab-logo.gif http://www.pharmajournalist.com/hope-biosciences-acquires-worldwide-rights-novel-mertkaxl-inhibitor-neopharm/ 2017-04-29T12:33:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/noxopharm-entered-research-agreement-university-hong-kong/ 2017-04-29T12:35:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/noxopharm-logo.jpg http://www.pharmajournalist.com/ipsen-acquire-primary-care-platform-italy-akkadeas-pharma/ 2017-04-29T12:36:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/gensight-biologics-receives-fda-orphan-drug-designation-gs030/ 2017-04-29T12:37:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/mallinckrodt-sell-intrathecal-therapy-business-piramal-enterprises-limited/ 2017-04-29T12:41:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/ferring-pharmaceuticals-enteris-biopharma-enter-license-agreement/ 2017-04-29T12:43:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Ferring-Pharmaceuticals-logo.png http://www.pharmajournalist.com/endo-announces-u-s-fda-approval-ephedrine-sulfate-injection-usp/ 2017-04-29T12:45:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/astellas-ironwood-report-positive-top-line-results-phase-iii-linaclotide-trial/ 2017-04-29T12:48:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/vicore-pharma-granted-orphan-drug-designation-fda-treatment-ipf/ 2017-04-29T12:52:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pilgrim-introduces-oos-management-software-support-pharmaceutical-manufacturing/ 2017-04-29T13:23:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/pilgrim-quality-solutions-logo.png http://www.pharmajournalist.com/cryolife-present-x-aortic-heart-valve-proact-results-aats/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/cryolife.jpg http://www.pharmajournalist.com/medite-cancer-diagnostics-announces-reorganization-germany-operations/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/medite-logo.jpg http://www.pharmajournalist.com/ai-shows-potential-fight-diabetic-blindness/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/american-academy-of-opthalmolo.png http://www.pharmajournalist.com/intrexon-appoints-lupin-ceo-vinita-gupta-board-directors/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/intrexon-logo.png http://www.pharmajournalist.com/pfizers-zavicefta-matches-standard-care-treating-hospital-acquired-pneumonia-phase-3-study/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/pfize.jpg http://www.pharmajournalist.com/bausch-lomb-receives-510k-clearance-fda-vitesse/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/valeant-pharma.jpg http://www.pharmajournalist.com/fda-expands-approved-use-stivarga-treat-liver-cancer/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-approves-first-treatment-form-batten-disease/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/new-spcma-white-paper-pbm-specialty-pharmacies-improve-patient-outcomes-reduce-costs/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/pcma-logo.jpg http://www.pharmajournalist.com/shalini-sharp-joins-array-biopharma-board-directors/ 2017-04-29T20:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/shalini-sharp-array.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/shalini-sharp-array.jpg http://www.pharmajournalist.com/jj-buys-3d-printing-tech-create-bone-healing-implants/ 2017-04-29T20:55:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/depuy.jpg http://www.pharmajournalist.com/tiziana-life-sciences-announces-approval-phase-ii-clinical-trial-protocol-milciclib/ 2017-04-29T20:55:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/ngm-bios-ngm282-succeeds-nonalcoholic-steatohepatitis-phase-2-trial/ 2017-04-29T20:55:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/novartis-expanded-commercialization-agreement-amgen-amg-334-erenumab/ 2017-04-29T20:55:45+00:00 http://www.pharmajournalist.com/astrazenecas-lung-cancer-drug-tagrisso-receives-full-approval-eu/ 2017-04-29T20:55:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/regen-biopharma-three-new-series-compounds-activate-nr2f6/ 2017-04-29T20:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/regen-biopharma.jpg http://www.pharmajournalist.com/novartiss-ctl019-receives-fda-breakthrough-therapy-designation/ 2017-04-29T20:55:46+00:00 http://www.pharmajournalist.com/japans-sawai-pharmaceutical-acquire-generics-business-u-s-upsher-smith-laboratories/ 2017-04-29T20:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/h3-biomedicine-extends-collaboration-foundation-medicine-develop-precision-therapies-cancer/ 2017-04-29T20:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/h3-Biomedicine.jpg http://www.pharmajournalist.com/phase-12-clinical-trial-agenus-anti-pd-1-antibody-begins/ 2017-04-29T20:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/veeva-introduces-vault-siteexchange-simplify-document-exchange-clinical-trials/ 2017-04-29T20:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/veeva-systems.png http://www.pharmajournalist.com/certara-introduces-comprehensive-solution-prepare-analyze-submit-pharmacokinetic-pk-data/ 2017-04-29T20:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/certara.png http://www.pharmajournalist.com/mateon-phase-23-study-platinum-resistant-ovarian-cancer-result-positive/ 2017-04-29T20:56:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mateon-therapeutics-logo.png http://www.pharmajournalist.com/roche-emicizumab-positive-result-children-haemophilia/ 2017-04-29T20:56:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/fda-advisory-committee-survey-pumas-nda-neratinib/ 2017-04-29T20:56:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/myokardia-appoints-david-meeker-md-board-directors/ 2017-04-29T20:56:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/myokardia.jpg http://www.pharmajournalist.com/abbott-alere-amend-terms-merger-agreement/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Abbott.png http://www.pharmajournalist.com/fda-allows-nuvox-pharma-run-phase-ii-clinical-trial-brain-cancer/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/nuvox-pharma.jpg http://www.pharmajournalist.com/ge-cbmg-collaborated-co-develop-car-t-stem-cell-manufacturing/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/CBMG-GE.jpg http://www.pharmajournalist.com/biocryst-explore-oral-liquid-formulation-bcx7353-use-acute-hae-attacks/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biocryst-pharma.jpg http://www.pharmajournalist.com/allergan-novartis-enters-clinical-collaboration-nash-treatment/ 2017-04-29T20:56:01+00:00 http://www.pharmajournalist.com/rigel-submits-nda-fda-fostamatinib-chronic-itp/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/ionis-ribo-enters-collaboration-rna-targeted-therapeutics/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ionis-pharma.jpg http://www.pharmajournalist.com/immune-therapeutics-clears-critical-regulatory-hurdle-lodonal-kenya/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/immune-therapeutics.jpg http://www.pharmajournalist.com/zymeworks-receives-second-orphan-drug-designation-zw25-gastric-cancer/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/zyme-works.jpeg http://www.pharmajournalist.com/inovio-pharmaceuticals-implement-pilgrim-quality-solutions-cloud/ 2017-04-29T20:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/pilgrim-quality-solutions-logo.png http://www.pharmajournalist.com/second-sights-argus-ii-retinal-prosthesis-implanted-first-patient-asia/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/second-sight.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/second-sight.jpg http://www.pharmajournalist.com/oncomeds-demcizumab-fails-to-meet-primary-endpoint-in-pancreatic-cancer-trial/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/1cellbio-inc-announces-collaboration-agreement-with-ucb/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/kyorin-acquired-licenses-from-merck-for-investigational-therapy-for-overactive-bladder-in-asia/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/merck-group.jpg http://www.pharmajournalist.com/medivirs-ctcl-drug-remetinostat-yields-positive-data-in-phase-ii-study/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/medivir.jpg http://www.pharmajournalist.com/karyopharm-and-medidata-expand-clinical-trial-partnership/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/karyopharma-logo.png http://www.pharmajournalist.com/jazz-pharmaceuticals-reaches-settlement-with-hikma-pharmaceuticals/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/therapix-signs-exclusive-license-agreement-with-yissum-research-development/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/therapix-biosciences.jpg http://www.pharmajournalist.com/peptidream-announces-discovery-collaboration-agreement-with-janssen/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/peptiDream-logo.jpg http://www.pharmajournalist.com/takeda-enters-into-strategic-collaboration-with-nubiyota-for-microbiome-therapeutics/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/neurocrines-ingrezza-capsule-approved-treat-tardive-dyskinesia/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/bill-sibold-appointed-sanofi-genzyme-vp-member-executive-committee/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bill-sibold-sanofi.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/04/bill-sibold-sanofi.jpg http://www.pharmajournalist.com/streamline-cdisc-electronic-data-submissions-technology-solution-cdisc-pk-study-data/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/certara.png http://www.pharmajournalist.com/amcor-announces-appointment-chief-commercial-officer/ 2017-04-29T20:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amcor.jpg http://www.pharmajournalist.com/mylan-completes-acquisition-of-cold-eeze-brand/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-pharma.jpg http://www.pharmajournalist.com/sonoma-pharmaceuticals-receives-u-s-fda-clearance-of-loyon-skin-descaler/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sonoma-pharmaceuticals.png http://www.pharmajournalist.com/sonoma-pharmaceuticals-receives-u-s-fda-clearance-loyon-skin-descaler/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/hilleman-laboratories-signs-mou-with-niced-icmr-to-develop-shigella-vaccine/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/hilleman-lab-logo.jpg http://www.pharmajournalist.com/biogen-wins-tecfidera-u-s-patent-dispute-with-forward-pharma/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bigen-logo.jpg http://www.pharmajournalist.com/puma-biotechnology-launches-expanded-access-program-for-pb272-neratinib/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/puma-biotechnology.jpg http://www.pharmajournalist.com/miragen-therapeutics-receives-orphan-drug-designation-for-mrg-106/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/miragen-therapeutics.jpg http://www.pharmajournalist.com/biocryst-announces-mundipharma-receives-approval-for-mundesine-in-japan/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biocryst-pharma-logo.jpg http://www.pharmajournalist.com/meiji-seika-and-eisai-enter-into-a-collaboration-for-the-development-and-commercialization-of-safinamide/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Meiji-Seika-Pharma-Logo.gif http://www.pharmajournalist.com/mylan-completes-acquisition-cold-eeze-brand/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/uniqure-publishes-data-demonstrating-wide-distribution-aav5-central-nervous-system/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/uniqure.jpg http://www.pharmajournalist.com/mylan-completes-acquisition-cold-eeze-brand-2/ 2017-04-29T20:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-1.jpg http://www.pharmajournalist.com/shangpharma-announces-strategic-corporate-restructuring-shanghai-chempartner/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/orexigen-therapeutics-announces-commercialization-distributorship-agreement-bruno-farmaceutici-s-p/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/chmp-provides-positive-opinion-for-eu-label-update-for-novo-nordisks-tresiba/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/newron-presents-results-of-its-phase-iia-study-with-evenamide-in-patients-with-schizophrenia/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/newron-pharmaceutical-logo.jpg http://www.pharmajournalist.com/orexigen-therapeutics-announces-commercialization-and-distributorship-agreement-with-bruno-farmaceutici-s-p-a/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/orexigen-logo.jpg http://www.pharmajournalist.com/allergan-and-paratek-announce-positive-results-from-two-phase-3-trials-of-sarecycline/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/allergan-logo.png http://www.pharmajournalist.com/allergan-paratek-announce-positive-results-two-phase-3-trials-sarecycline/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/c4-therapeutics-calico-enter-strategic-partnership-discover-novel-therapeutics/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/elbit-imaging-ltd-announces-ema-orphan-drug-designation-granted-gamida-cell/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/aprea-therapeutics-announces-research-collaboration-memorial-sloan-kettering-cancer-center/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/moleculin-receives-orphan-drug-designation-annamycin/ 2017-04-29T20:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/pierre-fabre-h-immune-announce-strategic-research-partnership/ 2017-04-29T20:57:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/pulmatrix-receives-european-patent-inhaled-drug-delivery-technology/ 2017-04-29T20:57:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/pulmatrix-inc-logo.jpg http://www.pharmajournalist.com/argenx-announces-collaboration-broteio-pharma-develop-therapeutic-antibody/ 2017-04-29T20:57:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/argenx-logo.jpg http://www.pharmajournalist.com/novaliq-gmbh-announces-licensing-agreement-aft-pharmaceuticals/ 2017-04-29T20:57:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/catalent-biologics-announces-appointment-matthew-stober-advisory-board/ 2017-04-29T20:57:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Catelent-Office.png http://www.pharmajournalist.com/pharmatek-adds-cgmp-spray-drying-capacity-response-demand-improved-pharmaceutical-solubility/ 2017-04-29T22:33:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Catelent-Office.png http://www.pharmajournalist.com/fda-grants-pfizers-lorlatinib-breakthrough-designation-nsclc/ 2017-04-29T22:38:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/pfize.jpg http://www.pharmajournalist.com/tesaro-initiates-registrational-development-program-anti-pd-1-antibody-tsr-042/ 2017-04-30T11:42:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/tesaro-inc-logo.jpg http://www.pharmajournalist.com/medtronic-receives-ide-approval-initiate-study-pact-admiral-drug-coated-balloon/ 2017-04-30T12:14:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/medtronics-logo.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/04/medtronics-logo.jpg http://www.pharmajournalist.com/crownbio-announces-expansion-life-science-division/ 2017-04-30T12:18:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/crownbio-logo.jpg http://www.pharmajournalist.com/european-commission-grants-orphan-drug-designation-cabiralizumab-fpa008/ 2017-04-30T12:21:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/five-prime-therapeutics-inc-lo.png http://www.pharmajournalist.com/evotec-enters-integrated-drug-discovery-collaboration-asahi-kasei-pharma-japan/ 2017-04-30T12:25:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/evotec-logo.jpg http://www.pharmajournalist.com/ethypharm-acquires-martindale-pharma-uk/ 2017-04-30T12:27:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ethypharm.jpg http://www.pharmajournalist.com/symbiomix-therapeutics-submits-new-drug-application-us-fda-solosec/ 2017-04-30T12:29:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/lilly-colucid-pharmaceuticals-announce-agreement-lilly-acquire-colucid/ 2017-04-30T12:33:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/colucid-pharma-logo.jpg http://www.pharmajournalist.com/takeda-ovid-therapeutics-announce-clinical-development-commercialization-collaboration-tak-935/ 2017-04-30T12:34:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/evotec-mars-innovation-establish-strategic-partnership-launch-fibrocor-therapeutics/ 2017-04-30T12:35:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/evotec-logo.jpg http://www.pharmajournalist.com/progenra-discovers-novel-immune-oncology-drug/ 2017-04-30T12:37:25+00:00 http://www.pharmajournalist.com/milliporesigma-opens-production-facility-exclusively-meglumine-spain/ 2017-04-30T12:39:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/milliporesigma-logo.jpg http://www.pharmajournalist.com/benitec-biopharma-receives-orphan-drug-designation-european-union-bb-301/ 2017-04-30T12:41:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Benitec-biopharma-logo.png http://www.pharmajournalist.com/brazil-issues-first-license-sale-cannabis-based-drug/ 2017-04-30T12:42:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/sunovion-announces-pivotal-study-results-novel-drug-candidate-dasotraline/ 2017-04-30T12:43:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sunovion-logo.jpg http://www.pharmajournalist.com/u-s-supreme-court-agrees-hear-dispute-biologic-drug-sales/ 2017-04-30T12:45:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/lupin-launches-generic-morphine-sulfate-tablets-us/ 2017-04-30T12:48:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/lupin-pharma.jpg http://www.pharmajournalist.com/kitov-pharmaceuticals-enters-immuno-oncology-field-acquisition-tyrnovo/ 2017-04-30T12:51:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/harrington-discovery-institute-alzheimers-drug-discovery-foundation-expand-collaboration/ 2017-04-30T12:52:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/espero-pharmaceuticals.jpg http://www.pharmajournalist.com/shionogi-announces-positive-top-line-results-cefiderocol-pivotal-cuti-clinical-trial/ 2017-04-30T12:54:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/shionogi-logo.jpg http://www.pharmajournalist.com/maverick-therapeutics-takeda-announce-five-year-collaboration-advance-t-cell-engagement-therapies/ 2017-04-30T12:56:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/aralez-pharmaceuticals-announces-issuance-additional-u-s-patent-yosprala/ 2017-04-30T12:58:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/aralez-pharmaceuticals-logo.png http://www.pharmajournalist.com/viracyte-granted-u-s-fda-fast-track-designation-viralym-c/ 2017-04-30T12:59:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/chi-med-initiates-hmpl-523-clinical-trials-hematological-cancer-china/ 2017-04-30T13:01:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/zebra-biologics-inc-collaborate-abbvie-discover-new-antibody-therapeutics/ 2017-04-30T13:06:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/takeda-acquire-ariad-pharmaceuticals-inc-5-2-billion/ 2017-04-30T13:07:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/pure-mhc-partner-abbvie-oncology-research/ 2017-04-30T13:11:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/emergent-logo.jpg http://www.pharmajournalist.com/ipsen-acquire-oncology-assets-merrimack-pharmaceuticals/ 2017-04-30T13:12:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/enzyvant-develop-novel-biologic-therapy-complete-digeorge-syndrome/ 2017-04-30T13:14:12+00:00 http://www.pharmajournalist.com/mast-therapeutics-savara-sign-merger-agreement/ 2017-04-30T13:16:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mast-therapeutics-logo.jpg http://www.pharmajournalist.com/ambrx-mabspace-biosciences-collaborate-novel-antibody-drug-conjugates/ 2017-04-30T13:27:27+00:00 http://www.pharmajournalist.com/ptc-therapeutics-announces-initiation-firefish-study-infant-type-sma-patients/ 2017-04-30T13:28:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/takeda-pharmaceutical-pvp-biologics-announce-development-agreement-around-novel-therapeutic-celiac-disease/ 2017-04-30T13:29:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/custopharm-acquires-two-anda-pharmaceutical-products-perrigo/ 2017-04-30T13:31:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/perrigo-company-logo.png http://www.pharmajournalist.com/us-fda-grants-orphan-drug-designation-yisheng-biopharmas-pika-rabies-vaccine/ 2017-04-30T13:31:51+00:00 http://www.pharmajournalist.com/senhwa-biosciences-cx-4945-granted-orphan-drug-designation-us-fda/ 2017-04-30T13:33:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/senhwa-biosciences-logo.jpg http://www.pharmajournalist.com/sharp-edge-labs-enters-drug-discovery-collaboration-sumitomo-dainippon-pharma/ 2017-04-30T13:34:41+00:00 http://www.pharmajournalist.com/marinus-pharmaceuticals-receives-fda-orphan-drug-designation-ganaxolone/ 2017-04-30T13:36:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/marinus-pharmaceuticals.jpg http://www.pharmajournalist.com/dermira-initiates-phase-3-clinical-program-acne/ 2017-04-30T13:38:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dermira-inc-logo.png http://www.pharmajournalist.com/suven-life-sciences-secures-two-2-product-patents-eurasia-norway/ 2017-04-30T13:40:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/suven-life-sciences-logo.jpg http://www.pharmajournalist.com/lupin-gets-usfda-nod-cevimeline-hydrochloride-capsules/ 2017-04-30T13:41:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/lupin-pharma.jpg http://www.pharmajournalist.com/sanofi-pasteur-msd-end-joint-vaccines-business-europe/ 2017-04-30T13:42:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi-image.jpg http://www.pharmajournalist.com/ibm-patents-machine-learning-models-drug-discovery/ 2017-04-30T13:59:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/IBM-Research.jpg http://www.pharmajournalist.com/dnatrix-licenses-myxoma-virus-new-immunotherapy-platform-2/ 2017-04-30T14:06:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dnatrix-therapeutics-logo.jpg http://www.pharmajournalist.com/dnatrix-announces-first-patients-treated-phase-2-trial-dnx-2401-keytruda/ 2017-04-30T14:07:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dnatrix-therapeutics-logo.jpg http://www.pharmajournalist.com/dnatrix-awarded-fda-orphan-products-development-grant-dnx-2401/ 2017-04-30T14:09:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dnatrix-therapeutics-logo.jpg http://www.pharmajournalist.com/dnatrix-receives-european-medicines-agency-prime-designation/ 2017-04-30T14:10:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dnatrix-therapeutics-logo.jpg http://www.pharmajournalist.com/dnatrix-announces-successful-intratumoral-delivery-dnx-2401-via-alcyones-mems-cannula-targeted-treatment-recurrent-glioblastoma/ 2017-04-30T14:11:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dnatrix-therapeutics-logo.jpg http://www.pharmajournalist.com/dnatrixs-oncolytic-immunotherapy-dnx-2401-awarded-eu-orphan-medicine-designation-treating-malignant-brain-tumors/ 2017-04-30T14:12:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dnatrix-therapeutics-logo.jpg http://www.pharmajournalist.com/merck-dnatrix-announce-phase-2-immuno-oncology-collaboration-patients-aggressive-form-brain-cancer/ 2017-04-30T14:14:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/dnatrix-therapeutics-logo.jpg http://www.pharmajournalist.com/benevolentai-announces-exclusive-license-agreement-janssen-clinical-stage-drug-candidates/ 2017-04-30T14:17:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/benevolentAI.jpg http://www.pharmajournalist.com/ibms-watson-helps-employees-tackle-cancer/ 2017-04-30T14:37:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/nexus-biopharma-signs-deal-transchem-kinase-inhibition-technology/ 2017-04-30T14:40:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/nexus-biopharma-inc-logo.jpg http://www.pharmajournalist.com/codexis-completes-transfer-codeevolver-technology-merck/ 2017-04-30T14:43:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/codexis-inc-logo.jpg http://www.pharmajournalist.com/bayer-delsitech-partner-develop-innovative-drug-delivery-technology-ophthalmology/ 2017-04-30T14:46:27+00:00 http://www.pharmajournalist.com/astrazeneca-selects-llamasoft-supply-chain-design-partner-choice/ 2017-04-30T14:49:49+00:00 http://www.pharmajournalist.com/ligand-enters-omniab-license-agreement-teneobio-inc/ 2017-04-30T14:53:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ligand-pharmaceuticals.png http://www.pharmajournalist.com/ligand-enters-commercial-license-supply-agreements-marinus-pharmaceuticals-captisol-enabled-ganaxolone/ 2017-04-30T14:55:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ligand-pharmaceuticals.png http://www.pharmajournalist.com/ligand-enters-commercial-license-supply-agreements-captisol-enabled-trametinib/ 2017-04-30T14:59:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ligand-pharmaceuticals.png http://www.pharmajournalist.com/pfizer-launches-app-moodivator-help-patients-manage-depression/ 2017-04-30T15:07:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Moodivator-on-Iphone.jpg http://www.pharmajournalist.com/epam-sinequa-partner-solve-cognitive-search-analytics-challenges-pharma-industry/ 2017-04-30T15:13:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/epam-systems.png http://www.pharmajournalist.com/milliporesigma-launches-new-gene-editing-technology-engineer-virus-resistant-cho-cell-lines/ 2017-04-30T15:20:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/CHO-Cell-Lines.jpg http://www.pharmajournalist.com/compugen-discloses-development-enhanced-links-platform-utilized-discovery-myeloid-targets-cancer-immunotherapy/ 2017-04-30T15:24:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/compugen-inc-logo.jpg http://www.pharmajournalist.com/daiichi-sankyo-selects-veeva-vault-streamline-submissions-etmf-quality-management/ 2017-04-30T15:27:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/veeva-systems.png http://www.pharmajournalist.com/eleven-biotherapeutics-completes-exclusive-licensing-deal-il-6-antagonist-antibody-technology/ 2017-04-30T15:31:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/eleven-biotherapeutics-logo.jpg http://www.pharmajournalist.com/genmab-enters-commercial-license-agreement-gilead-duobody-technology/ 2017-04-30T15:33:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gilead.jpg http://www.pharmajournalist.com/lantern-pharma-announces-transaction-evaluate-bionumeriks-tavocept/ 2017-04-30T15:37:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/lantern-pharma-logo.png http://www.pharmajournalist.com/pluristem-therapeutics-deploys-medidatas-cloud-technology/ 2017-04-30T15:41:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Pluristem-therapeutics.jpg http://www.pharmajournalist.com/ligand-announces-multi-program-ltp-technology-licensing-agreement-nucorion-pharmaceuticals/ 2017-04-30T15:44:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ligand-pharmaceuticals.png http://www.pharmajournalist.com/synaffix-achieves-improved-therapeutic-index-compared-fda-approved-adcs/ 2017-04-30T15:47:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/synaffix-logo.jpg http://www.pharmajournalist.com/peptidream-announces-license-pdps-technology-genentech/ 2017-04-30T15:50:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/peptiDream-logo.jpg http://www.pharmajournalist.com/hanmi-selects-medidata-power-drug-development-cloud-technology/ 2017-04-30T15:53:15+00:00 http://www.pharmajournalist.com/pfizer-selects-oracle-cloud-clinical-data-management-trial-management/ 2017-04-30T15:56:12+00:00 http://www.pharmajournalist.com/virtual-reality-app-offers-unique-glimpse-life-dementia/ 2017-04-30T16:01:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/a-walk-through-dementia.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/a-walk-through-dementia.jpg http://www.pharmajournalist.com/kalytera-licenses-transdermal-drug-delivery-technology-delivra-corp/ 2017-04-30T16:05:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/kalytera-therapeutics.png http://www.pharmajournalist.com/integral-molecular-develops-b-cell-cloning-technology-discover-rare-antibodies-membrane-proteins/ 2017-04-30T16:09:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/jhl-biotech-selects-paizabio-provide-fill-finish-cmo-services-groundbreaking-therapies/ 2017-04-30T16:12:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/paizabio-logo.jpg http://www.pharmajournalist.com/bayer-ers-genomics-announce-licensing-agreement-genome-editing-patents/ 2017-04-30T16:14:50+00:00 http://www.pharmajournalist.com/scientists-discover-new-technology-breakthrough-fighting-viral-diseases/ 2017-04-30T16:17:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/using-gene-editing-technology-faster-cheaper-antiviral-drug-development/ 2017-04-30T16:22:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/RobertMSSR_mid.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/RobertMSSR_mid.jpg http://www.pharmajournalist.com/ibc-generium-selects-goodwin-biotechnology-optimize-process-igg-based-bispecific-antibody/ 2017-04-30T16:27:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ibc-generium-logo.jpg http://www.pharmajournalist.com/bioasis-technologies-enters-license-agreement-astellas-research-institute-america-llc/ 2017-04-30T16:31:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/bms-selects-medidata-clinical-cloud-drive-drug-development-business-transformation/ 2017-04-30T16:35:21+00:00 http://www.pharmajournalist.com/halo-pharmaceutical-exxpharma-partner-develop-products-using-twin-screw-extrusion-technology/ 2017-04-30T16:39:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/halo-pharma-logo.jpg http://www.pharmajournalist.com/glaxosmithkline-selects-tierpoint-support-global-data-consolidation-recovery-operations/ 2017-04-30T16:41:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/oracle-delivers-complete-cloud-solution-help-pharma-companies-improve-drug-safety/ 2017-04-30T16:44:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/oracle-logo.jpg http://www.pharmajournalist.com/supernus-pharmaceuticals-selects-dsg-inc-edc-iwrs-phase-3-clinical-studies/ 2017-04-30T16:47:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/supernus-pharmaceuticals-inc-logo.jpg http://www.pharmajournalist.com/eisai-signs-three-year-contract-extension-cscs-trs-service/ 2017-04-30T16:51:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/eisai-logo.jpg http://www.pharmajournalist.com/marina-biotech-announces-license-agreement-deliver-genome-editing-technology/ 2017-04-30T16:54:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/marina-biotech.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/marina-biotech.jpg http://www.pharmajournalist.com/new-england-biolabs-selects-symmetry-comprehensive-sap-hana-cloud-migration/ 2017-04-30T16:58:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/symmetry-corp-logo.jpg http://www.pharmajournalist.com/genomics-england-selects-qiagen-hereditary-rare-disease-solution/ 2017-04-30T17:39:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/medidatas-cloud-technology-powers-u-s-government-research-drug-development-costs/ 2017-04-30T17:43:27+00:00 http://www.pharmajournalist.com/grunenthal-selects-patheon-develop-drugs-using-intac-abuse-deterrent-formulations-technology/ 2017-04-30T17:45:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/oracle-health-sciences-provide-clinical-e-monitoring-solution-bayer-healthcare/ 2017-04-30T17:46:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/oracle-logo.jpg http://www.pharmajournalist.com/panacea-pharmaceuticals-selects-goodwin-develop-anti-cancer-monoclonal-antibody/ 2017-04-30T17:49:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/panacea-pharmaceuticals.jpg http://www.pharmajournalist.com/oracle-powers-precision-medicine-delivery-new-solution-connecting-research-pathology-clinical-care/ 2017-04-30T17:51:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/oracle-logo.jpg http://www.pharmajournalist.com/ono-pharmaceutical-expands-adoption-medidata-clinical-cloud-platform/ 2017-04-30T17:53:06+00:00 http://www.pharmajournalist.com/pathcore-selected-national-cancer-institute-enable-cancer-informatics-development/ 2017-04-30T17:56:56+00:00 https://pharmajournalist.com/wp-content/uploads/2016/01/pathcore-logo.png http://www.pharmajournalist.com/boehringer-ingelheim-selects-medidata-clinical-cloud-accelerate-innovation-drug-development/ 2017-04-30T18:00:22+00:00 http://www.pharmajournalist.com/xl-protein-easton-sign-license-agreement-develop-biopharmaceuticals-using-pasylation-technology/ 2017-04-30T18:03:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/biovicas-divitum-technology-selected-new-cancer-drug-trial/ 2017-04-30T18:06:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biovica-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/biovica-pharma.jpg http://www.pharmajournalist.com/parexel-launches-impact-express-clinical-trial-management-system/ 2017-04-30T19:32:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/parexel-clinical.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/parexel-clinical.jpg http://www.pharmajournalist.com/siemens-receives-fda-clearance-multitom-rax-robotic-x-ray-system/ 2017-04-30T19:35:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/crown-bioscience-offers-unique-immuno-oncology-translational-research-platform/ 2017-04-30T20:14:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/crownbio-logo.jpg http://www.pharmajournalist.com/parexel-enhances-end-end-clinical-development-services/ 2017-04-30T20:17:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/parexel-clinical.jpg http://www.pharmajournalist.com/meridian-bioscience-announces-investment-oasis-diagnostics/ 2017-04-30T20:19:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/meridian-biosciences-inc-logo.jpg http://www.pharmajournalist.com/essential-pharmaceuticals-releases-cell-ess-media-supplement-proteins-vaccines-bioproduction/ 2017-04-30T20:22:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/essential-pharmaceuticals.jpg http://www.pharmajournalist.com/amcor-flexibles-launches-first-wave-european-healthcare-printing-investments/ 2017-04-30T20:35:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amcor-flexibles.jpg http://www.pharmajournalist.com/amcor-showcase-latest-packaging-solutions-interpack-2017/ 2017-04-30T20:38:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amcor-innovation-products.jpg http://www.pharmajournalist.com/healthcare-industry-europe-benefits-scale-amcors-short-run-print-services/ 2017-04-30T20:40:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amcor-flexibles.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-announces-first-ever-cloud-based-application-connectivity-electronic-pipettes/ 2017-04-30T20:45:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific-logo.jpg http://www.pharmajournalist.com/acquisition-fargo-automation-inc-korber-ag-concluded/ 2017-04-30T20:55:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Acquisition-of-Fargo-Automation-Inc.jpg http://www.pharmajournalist.com/korber-ag-plans-acquire-fargo-automation-inc/ 2017-04-30T20:59:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/koerber-plans-to-acquire-fargo.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/koerber-plans-to-acquire-fargo.jpg http://www.pharmajournalist.com/werum-solutions-nne-pharmaplan-renew-long-lasting-service-partnership-europe-usa-china/ 2017-04-30T21:01:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/werum-IT-Solutions-gmbh.jpg http://www.pharmajournalist.com/gerresheimer-optimizes-cold-end-operations-pharma-glass-production-plants-state-art-packing-robots/ 2017-04-30T22:53:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gerresheimer.png http://www.pharmajournalist.com/bosch-packaging-expands-pharmaceutical-portfolio/ 2017-04-30T22:56:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bosch-packaging.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/bosch-packaging.jpg http://www.pharmajournalist.com/sharp-packaging-services-selects-tracelink-achieve-dscsa-compliance-100-pharmaceutical-manufacturers/ 2017-04-30T22:57:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sharp-clinical-services.jpg http://www.pharmajournalist.com/china-restructures-drug-pricing-regime/ 2017-04-30T23:09:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Convington-logo.gif http://www.pharmajournalist.com/challenges-opportunities-specialty-pharmacy-space/ 2017-05-01T11:13:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/DMD-logo.png http://www.pharmajournalist.com/percentage-based-dir-fees-limit-access-life-saving-specialty-medications/ 2017-05-01T11:17:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/nasp.png http://www.pharmajournalist.com/asthma-treatments-significant-unmet-needs-may-addressed-calcilytics-says-gbi-research/ 2017-05-01T11:21:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/gbi-research-logo.png http://www.pharmajournalist.com/gbi-research-emerging-field-cannabinoid-based-products/ 2017-05-01T11:25:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/gbi-research-logo.png http://www.pharmajournalist.com/engene-appoints-theresa-podrebarac-cmo/ 2017-05-01T14:08:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/engene-inc-logo.jpg http://www.pharmajournalist.com/allergan-completes-acquisition-zeltiq-aesthetic/ 2017-05-01T14:12:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/allergan.jpg http://www.pharmajournalist.com/medmira-receives-ce-marks-syphilishiv-rapid-test/ 2017-05-01T14:15:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/medmira-hepatitis-c-rapid-test.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/medmira-hepatitis-c-rapid-test.jpg http://www.pharmajournalist.com/fda-approves-rydapt-combination-chemotherapy-treatment-aml/ 2017-05-01T14:16:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/dr-wilson-appointed-tapimmune-president-dr-bonfiglios-resignation/ 2017-05-01T14:19:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/taplmmune-inc-logo.jpg http://www.pharmajournalist.com/agreement-buy-f-star-alpha-bristol-myers-squibb-f-star-alpha-terminated/ 2017-05-01T14:23:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/patheon-agrees-buy-roches-api-manufacturing-plant-south-carolina/ 2017-05-02T05:32:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/logo-Patheon.png http://www.pharmajournalist.com/west-pharmaceutical-services-expands-contract-manufacturing-capabilities-ireland/ 2017-05-02T05:32:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/West-Pharmaceutical.png http://www.pharmajournalist.com/finch-therapeutics-announces-strategic-collaboration-openbiome/ 2017-05-02T05:32:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/espero-pharmaceuticals.jpg http://www.pharmajournalist.com/allergan-successfully-completes-lifecell-acquisition/ 2017-05-02T05:32:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/allergan-logo.png http://www.pharmajournalist.com/transgene-institut-bergonie-start-phase-2-part-metromajx-trial/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/accenture-biocelerate-join-hands-advance-biopharmaceutical-innovation/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/accenture-logo.jpg http://www.pharmajournalist.com/intec-pharma-initiates-phase-trial-accordion-pill-cannabinoid-therapies/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/gerrit-dispersyn-rxi-pharmaceuticals-new-chief-development-officer/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Gerrit-Dispersyn-RXI-pharmaceuticals.jpg http://www.pharmajournalist.com/reform-biologics-appoints-john-m-sorvillo-ceo/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/john-m-sorvillo-ceo.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/john-m-sorvillo-ceo.jpg http://www.pharmajournalist.com/catalent-expands-kansas-city-clinical-storage-secondary-packaging-capabilities/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Catelent-Office.png http://www.pharmajournalist.com/ubp-selects-ge-flexfactory-platform-new-facility-hsinchu-industrial-park/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ge-healthcare-flexfactory-1.jpg http://www.pharmajournalist.com/sutro-biopharma-appoints-joseph-m-lobacki-director/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/suntro-biopharma.png http://www.pharmajournalist.com/wp-content/uploads/2017/04/suntro-biopharma.png http://www.pharmajournalist.com/takeda-harrington-advance-development-rare-disease-therapeutics/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/recipharm-opens-new-gmp-suite-clinical-trial-material/ 2017-05-02T05:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/recipharm-logo.jpg http://www.pharmajournalist.com/abzena-signs-antibody-manufacturing-development-deal-university-college-london/ 2017-05-02T05:33:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/ppd-expands-nephrology-capabilities-collaboration-frenova/ 2017-05-02T05:33:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/amri-entered-agreement-ferrer-accord-healthcare/ 2017-05-02T05:33:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/espero-pharmaceuticals.jpg http://www.pharmajournalist.com/edge-therapeutics-announces-18-million-registered-direct-offering-common-stock/ 2017-05-02T05:34:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/edge-therapeutics-inc.jpg http://www.pharmajournalist.com/lyndra-raises-23-million-series-financing-advance-ultra-long-acting-oral-therapeutic-delivery/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/lyndra-inc.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/lyndra-inc.jpg http://www.pharmajournalist.com/grifols-donates-140-million-iu-blood-clotting-factors-wfh-humanitarian-aid-program/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/grifols.png http://www.pharmajournalist.com/sharp-announces-9-million-investment-european-clinical-services-centre-excellence/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sharp-clinical-services.jpg http://www.pharmajournalist.com/servier-cti-biopharma-expands-collaboration-commercialize-pixuvri/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/john-tucker-appointed-ceo-scpharmaceuticals/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/science-37-raises-29m-bring-clinical-trials-directly-patients-homes/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/savara-announces-closing-merger-mast-therapeutics/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/savara-pharma.png http://www.pharmajournalist.com/merck-divests-biosimilars-business-fresenius/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/merck-group.jpg http://www.pharmajournalist.com/portola-pharmaceuticals-signs-150-million-royalty-agreement-healthcare-royalty-partners-development-commercialization-andexanet-alfa/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/espero-pharmaceuticals.jpg http://www.pharmajournalist.com/mallinckrodt-completes-sale-nuclear-imaging-business-iba-molecular-690-million/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/xtl-biopharmaceuticals-appoints-mr-alex-rabinovich-board-directors/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/xtl-biopharmaceuticals.jpg http://www.pharmajournalist.com/biocon-ltd-wins-myr-300-million-contract-insulin-moh-malaysia/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biocon.jpg http://www.pharmajournalist.com/lupin-receives-fda-approval-generic-benicar-tablets/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/lupin-pharma.jpg http://www.pharmajournalist.com/valeant-pharmaceuticals-sell-dendreon-sanpower-group-819-9-million/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/valeant-pharma.jpg http://www.pharmajournalist.com/amcors-new-site-bottle-manufacturing-drives-efficiency-sustainability-campbells-plant/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amcor-1.jpg http://www.pharmajournalist.com/bd-invests-100-million-nebraska-plant-expand-insulin-syringe-manufacturing/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bd-logo.png http://www.pharmajournalist.com/merck-invests-e-50-million-flagship-pharmaceutical-packaging-building-darmstadt/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/merck-group.jpg http://www.pharmajournalist.com/sorrento-therapeutics-successfully-completes-acquisition-virttu-biologics/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/agios-aurigene-signs-agreement-develop-small-molecule-inhibitors-cancer-metabolism-target/ 2017-05-02T05:34:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/glucome-appoints-john-erickson-evp-general-manager-north-america/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/glucome.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/glucome.jpg http://www.pharmajournalist.com/perrigo-completes-divestiture-tysabri-royalty-stream-2-85-billion/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/icon-bioscience-submits-nda-dexycu/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/immuno-oncology-company-agenus-to-cut-50-jobs-in-reorganization/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agenus.jpg http://www.pharmajournalist.com/perrigo-completes-divestiture-of-tysabri-royalty-stream-for-up-to-2-85-billion/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/perrigo-company-logo.png http://www.pharmajournalist.com/vanda-and-ucsf-announce-license-agreement-for-cftr-activators-and-inhibitors/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/vanda-pharmaceuticals-logo.jpg http://www.pharmajournalist.com/aimmune-therapeutics-appoints-eric-bjerkholt-chief-financial-officer/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/erik-bjerkholt.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/erik-bjerkholt.jpg http://www.pharmajournalist.com/vanda-ucsf-announce-license-agreement-cftr-activators-inhibitors/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/espero-pharmaceuticals-and-armetheon-to-merge/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/espero-pharmaceuticals.jpg http://www.pharmajournalist.com/astellas-to-acquire-ogeda-sa/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas-pharma-logo.jpg http://www.pharmajournalist.com/fda-approves-two-hepatitis-c-drugs-for-pediatric-patients/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/recipharm-delivers-first-serialised-batch-saudi-arabia/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/recipharm-logo.jpg http://www.pharmajournalist.com/biolinerx-announces-acquisition-agalimmune-ltd/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/bms-enters-two-separate-agreement-biogen-roche/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/novartis-licence-ecf843-strengthen-rd-pipeline/ 2017-05-02T05:35:18+00:00 http://www.pharmajournalist.com/fda-approves-prometics-pbi-4050-clinical-trial-design/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/regeneron-sanofi-receive-positive-chmp-opinion-kevzara-sarilumab/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi.jpg http://www.pharmajournalist.com/feinstein-institute-therasource-receive-grant-test-novel-sepsis-therapy/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/The-Feinstein-Institute-for-Medical-Research.jpg http://www.pharmajournalist.com/sharp-acquires-daiichi-sankyo-pharmaceutical-packaging-facility-bethlehem-pa/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sharp-clinical-services.jpg http://www.pharmajournalist.com/uniqure-announces-will-not-seek-marketing-authorization-renewal-glybera-europe/ 2017-05-02T05:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/uniqure.jpg http://www.pharmajournalist.com/oxford-biodynamics-participates-in-rheumatoid-arthritis-triggers-study/ 2017-05-02T05:35:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/oxford-biodynamics.jpg http://www.pharmajournalist.com/bristol-myers-squibb-cytomx-therapeutics-extend-worldwide-collaboration-discover-probody-therapeutics/ 2017-05-02T05:35:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/mallinckrodt-completes-sale-intrathecal-therapy-business-piramal-enterprises-limited/ 2017-05-02T05:35:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/acura-pharmaceuticals-mainpointe-pharmaceuticals-announce-deal-nexafed-products/ 2017-05-02T05:35:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/threshold-pharmaceuticals-molecular-templates-agree-combine/ 2017-05-02T05:35:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/threshold-pharma.jpg http://www.pharmajournalist.com/trovagene-nerviano-announce-license-agreement-therapeutic-candidate-pcm-075/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/mylan-launches-generic-pristiq-tablets/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan.jpg http://www.pharmajournalist.com/apricus-biosciences-announces-sale-ex-u-s-vitaros-assets-rights-ferring-pharmaceuticals/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/beigene-guangzhou-development-district-establish-joint-venture-build-biologics-manufacturing-facility/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/vernalis-plc-servier-enter-new-drug-discovery-collaboration/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/sartorius-acquire-u-s-based-essen-bioscience/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/espero-pharmaceuticals.jpg http://www.pharmajournalist.com/otsuka-pharmaceutical-acquire-neurovance-inc/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/lilly-completes-acquisition-colucid-pharmaceuticals/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/glenmark-pharmaceuticals-evestra-inc-announce-partnership-agreement-generic-nuvaring/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/perrigo-signs-agreement-divest-tysabri-royalty-stream-2-85-billion/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/perrigo-company-logo.png http://www.pharmajournalist.com/arsanis-inc-adimab-enter-license-agreement/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/sanofi-lonza-enter-strategic-partnership-establish-large-scale-biologics-production-facility/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi-image.jpg http://www.pharmajournalist.com/intellipharmaceutics-announces-fda-approval-500-mg-750-mg-generic-glucophage-xr/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/ani-pharmaceuticals-acquires-inderal-xl-innopran-xl/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/enrollment-completed-ligands-phase-2-trial-lgd-6972-type-2-diabetes/ 2017-05-02T05:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ligand-pharmaceuticals.png http://www.pharmajournalist.com/mental-health-insurance-industry-perspective/ 2017-05-02T05:42:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/inventiv-health.jpg http://www.pharmajournalist.com/top-5-reasons-outsource-site-payments-process/ 2017-05-02T05:57:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/drugdev.png http://www.pharmajournalist.com/eyelock-know-biometrics-cloud/ 2017-05-02T06:06:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/eyelock.jpg http://www.pharmajournalist.com/lexisnexis-risk-solutions-launches-offering-help-life-sciences-organizations-understand-navigate-complex-idns/ 2017-05-02T06:11:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lexisnexis.jpg http://www.pharmajournalist.com/shire-parion-sciences-enter-collaborative-license-agreement-advance-p-321-ophthalmic-indications/ 2017-05-02T12:41:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/shire-pharmaceuticals.jpg http://www.pharmajournalist.com/gsk-invests-139-million-expand-production-capacity-benlysta-belimumab-rockville-md/ 2017-05-02T12:42:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/neurotrope-announces-positive-top-line-results-phase-2-study-bryostatin-1-moderate-severe-alzheimers-disease/ 2017-05-02T12:44:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/neurotrope-inc-logo.jpg http://www.pharmajournalist.com/sunesis-pharmaceuticals-announces-withdrawal-european-maa-vosaroxin-treatment-relapsedrefractory-aml/ 2017-05-02T12:49:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sunesis-pharma-logo.jpg http://www.pharmajournalist.com/atlantic-healthcare-initiates-fda-rolling-submission-new-drug-application-alicaforsen-treatment-pouchitis/ 2017-05-02T12:54:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/nanotherapeutics-bohumil-s-r-o-praha-vaccines-s-finalize-transfer-human-vaccine-manufacturing-enterprise-czech-republic/ 2017-05-02T13:01:06+00:00 http://www.pharmajournalist.com/bioaxone-biosciences-continues-plans-growth-manufacturing-contract/ 2017-05-02T13:04:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/bioaxone-biosciences.jpg http://www.pharmajournalist.com/bluebird-bio-licenses-lentiviral-vector-patent-rights-development-commercialization-cell-therapies/ 2017-05-02T13:07:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/bluebird-bio-inc.jpg http://www.pharmajournalist.com/pillsy-launches-first-smart-pill-bottle-mobile-app/ 2017-05-02T13:10:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/pillsy-combo-pack.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/pillsy-combo-pack.jpg http://www.pharmajournalist.com/bluebird-bio-enters-lentiviral-vector-patent-license-agreement-gsk-commercialization-gene-therapies/ 2017-05-02T13:12:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/aries-pharmaceuticals-launches-eleview-use-gastrointestinal-endoscopic-procedures/ 2017-05-02T13:14:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/aries-pharmaceuticals.png http://www.pharmajournalist.com/verastem-appoints-eric-k-rowinsky-board-directors/ 2017-05-02T13:17:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/verastem-logo.png http://www.pharmajournalist.com/match-biotherapies-announces-collaboration-agreement-magenta-therapeutics/ 2017-05-02T13:20:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/bethematchbiotherapies.jpg http://www.pharmajournalist.com/nightstarx-appoints-ophthalmology-industry-veteran-scott-whitcup-board-directors/ 2017-05-02T13:23:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/nightstar-limited.jpg http://www.pharmajournalist.com/concert-pharmaceuticals-initiates-ctp-543-phase-2-trial-alopecia-areata/ 2017-05-02T13:37:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/clinical-trial-result-marks-significant-accomplishment-medicortex-finland/ 2017-05-02T13:40:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/medicortex-finland-oy.jpeg http://www.pharmajournalist.com/bayer-appoints-bhavesh-ashar-lead-u-s-oncology-business/ 2017-05-02T13:43:51+00:00 http://www.pharmajournalist.com/stealth-biotherapeutics-initiates-phase-12-trial-sbt-20-patients-early-stage-huntingtons-disease/ 2017-05-02T13:46:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/stealth-biotherapeutics.png http://www.pharmajournalist.com/oramed-receives-israel-regulatory-approval-conduct-human-study-new-oral-leptin-capsule/ 2017-05-02T13:48:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/oramed-pharma-logo.png http://www.pharmajournalist.com/imprimis-pharmaceuticals-sightlife-surgical-sign-agreement-national-launch-serum-tears/ 2017-05-02T13:53:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/imprimisrx.jpg http://www.pharmajournalist.com/amri-receives-nih-contract-award-drug-substance-development-manufacturing-services/ 2017-05-02T14:06:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/amriglobal.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/amriglobal.jpg http://www.pharmajournalist.com/propanc-biopharma-provides-update-imp-manufacture-prp-first-human-studies/ 2017-05-02T14:18:51+00:00 http://www.pharmajournalist.com/sandoz-canada-launches-sandoz-olmesartan-treatment-high-blood-pressure/ 2017-05-02T14:21:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/callery-corporation-appoints-dr-harry-rathore-ceo/ 2017-05-04T19:43:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Callery-Corporation.png http://www.pharmajournalist.com/david-price-appointed-chief-financial-officer-concordia-international/ 2017-05-04T19:45:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/concordia-international-corp.jpg http://www.pharmajournalist.com/sobi-appoints-guido-oelkers-new-president-ceo/ 2017-05-04T19:49:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Sobi-logo.jpg http://www.pharmajournalist.com/cannabics-pharmaceutical-collaborates-ctc-european-lab/ 2017-05-04T19:53:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/collaboration.png http://www.pharmajournalist.com/carsgen-announces-opening-car-t-cell-manufacturing-facility-shanghai/ 2017-05-04T19:55:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/carsgen-manufacturing-facility-opening.png http://www.pharmajournalist.com/biopharmx-achieves-primary-endpoint-phase-2b-clinical-trial-evaluating-bpx-011/ 2017-05-04T19:58:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/biopharmx.png https://pharmajournalist.com/wp-content/uploads/2017/05/biopharmx.png http://www.pharmajournalist.com/vivet-therapeutics-recieves-e37-5-million-series-financing-advancement-metabolic-diseases-treatment/ 2017-05-04T20:00:38+00:00 http://www.pharmajournalist.com/dragonfly-therapeutics-appointed-dr-asya-grinberg-head-biologics/ 2017-05-04T20:03:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dragonfly-therapeutics.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/dragonfly-therapeutics.jpg http://www.pharmajournalist.com/concordian-international-appoints-tzhak-krinsky-francis-perier-jr-members-board-directors/ 2017-05-04T20:08:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/concordia-international-corp.jpg http://www.pharmajournalist.com/sorrento-announces-completion-gmp-manufacturing-plant-suzhou/ 2017-05-06T12:27:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/sgs-announces-completion-phase-flu-trials-healthy-volunteers/ 2017-05-06T12:29:05+00:00 http://www.pharmajournalist.com/alcami-corporation-invest-5-million-expand-charleston-county-operations/ 2017-05-06T12:32:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/alcani-corporation-logo.jpg http://www.pharmajournalist.com/quivive-pharma-camargo-pharmaceutical-services-join-hands-development-programs/ 2017-05-06T12:34:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/collaboration.png http://www.pharmajournalist.com/provista-appoints-jim-cunniff-new-president-ceo/ 2017-05-06T12:38:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Provista-Logo.jpg http://www.pharmajournalist.com/corvus-pharmaceutical-expands-collaboration-genentech/ 2017-05-06T12:41:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/epizyme-earns-10-million-gsk-glp-toxicology-studies/ 2017-05-06T12:47:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/epizyme-logo.jpg http://www.pharmajournalist.com/astrazeneca-enters-2-1-billion-collaboration-pieris-drug-research/ 2017-05-06T12:48:50+00:00 http://www.pharmajournalist.com/gensight-appoints-mohamed-genead-cmo/ 2017-05-06T12:50:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/gensight.jpg http://www.pharmajournalist.com/teva-active-biotech-announce-results-concerto-trial-not-meet-primary-endpoint/ 2017-05-08T22:33:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/TEVA-Pharma.jpg http://www.pharmajournalist.com/fda-approves-mt-pharma-americas-radicava-als-treatment/ 2017-05-08T22:35:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/cosmo-pharmaceuticals-eleview-shows-successful-results-clinical-trial/ 2017-05-08T22:39:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/clinical-trials-cosmo-pharma.png https://pharmajournalist.com/wp-content/uploads/2017/05/clinical-trials-cosmo-pharma.png http://www.pharmajournalist.com/durect-sandoz-signs-293-million-agreement-posimir-saber-bupivacaine/ 2017-05-08T22:40:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/lamellar-biomedical-raises-funding-5-75-million/ 2017-05-08T22:43:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/funding.jpg http://www.pharmajournalist.com/opsis-therapeutics-announces-sab-advancement-retinal-cell-therapies/ 2017-05-08T22:47:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/opsis-therapeutics-logo.png http://www.pharmajournalist.com/biolase-initiate-search-new-cfo/ 2017-05-08T22:50:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Biolase-logo.jpg http://www.pharmajournalist.com/ani-launch-first-pindolol-tablets/ 2017-05-09T15:37:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/takeda-gammadelta-collaborates-develop-novel-t-cell-platform/ 2017-05-09T15:45:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/yong-ben-appointed-chief-medical-officer-bioatla/ 2017-05-09T15:49:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/bioalta-logo.jpg http://www.pharmajournalist.com/crown-bioscience-collaborates-jiangsu-qyun-bio-pharmaceutical-develop-antibody/ 2017-05-11T06:37:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/crownbio-logo.jpg http://www.pharmajournalist.com/inc-research-inventiv-health-approves-merge-agreement/ 2017-05-11T15:22:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/inventiv-health.jpg http://www.pharmajournalist.com/catalent-commercially-manufacture-lexicon-xermelo-following-fda-approval/ 2017-05-11T15:24:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Catelent-Office.png http://www.pharmajournalist.com/lensar-pdl-announces-completion-lensars-financial-restructuring/ 2017-05-11T15:26:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/PDL-Biopharma.jpg http://www.pharmajournalist.com/avita-medical-filed-ipr-petition-patent-owned-renovacare-sciences/ 2017-05-11T15:29:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/avita-medical-logo.png http://www.pharmajournalist.com/novocure-elects-martin-j-madden-board-directors/ 2017-05-11T15:31:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/novocure-logo.jpg http://www.pharmajournalist.com/dr-sandeep-reddy-appointed-cmo-nanthealth/ 2017-05-11T15:32:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/nanthealth-logo.jpg http://www.pharmajournalist.com/fda-authorizes-nant-cancer-vaccine-clinical-trial/ 2017-05-11T15:34:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/norgine-merus-labs-enter-merger-agreement/ 2017-05-11T15:35:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-authorizes-flourish-pediatric-esophageal-atresia-anastomosis-treat-esophageal-atresia/ 2017-05-15T11:57:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/merck-collaborates-stelis-biopharma-open-joint-process-scale-lab-india/ 2017-05-15T12:00:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/merck-group.jpg http://www.pharmajournalist.com/pfizer-pcv13-vaccine-selected-immunization-program-indian-babies/ 2017-05-15T12:02:35+00:00 http://www.pharmajournalist.com/siemens-imricor-partners-develop-mri-scan-3d-guided-cardiac-ablation/ 2017-05-15T12:10:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/siemens-healthineers.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/siemens-healthineers.jpg http://www.pharmajournalist.com/jose-carmona-appointed-cfo-radius-health/ 2017-05-16T14:12:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Radius-Health-Logo.jpg http://www.pharmajournalist.com/delmar-collaborates-pra-health-sciences-phase-3-trial-val-083/ 2017-05-16T14:14:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/patheon-invested-26-million-update-sterile-pds-suite-greenville-site/ 2017-05-16T14:15:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/logo-Patheon.png http://www.pharmajournalist.com/thermo-fisher-scientific-acquire-patheon-7-2-billion/ 2017-05-16T14:17:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/catalent-pharma-collaborate-therachon-development-ta-46/ 2017-05-16T14:19:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Catelent-Office.png http://www.pharmajournalist.com/biogen-acquires-remedy-pharmaceuticals-phase-3-candidate-cirara/ 2017-05-16T14:22:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/biogen-logo.jpg http://www.pharmajournalist.com/akebia-vifor-pharma-announce-exclusive-license-agreement-sell-vadadustat-us-clinics/ 2017-05-16T14:24:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/akebia-pharma-logo.png http://www.pharmajournalist.com/fda-awards-proteon-therapeutics-breakthrough-therapy-designation/ 2017-05-16T14:57:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/proteon-therapeutics-logo.png http://www.pharmajournalist.com/bms-calithera-biosciences-expand-collaboration-evaluate-opdivo-combined-cb-839-nsclc-patients/ 2017-05-18T05:38:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/halo-pharma-announces-formation-pediatric-center-excellence/ 2017-05-18T05:41:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/halo-pharma.jpg http://www.pharmajournalist.com/cambrex-invests-2-4m-increase-pilot-scale-capacity-high-point-facility/ 2017-05-18T05:45:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/cambrex-logo.png http://www.pharmajournalist.com/systimmune-selects-milliporesigmas-chozn-expression-system-bi-specific-antibody-development/ 2017-05-18T05:53:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/milliporesigma-logo.jpg http://www.pharmajournalist.com/russian-federation-approves-multi-dosage-cgmp-certificate-saneca-pharma/ 2017-05-18T05:59:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/saneca-pharma.jpg http://www.pharmajournalist.com/donna-morgan-murray-nativis-chief-regulatory-officer/ 2017-05-18T06:05:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Donna-Morgan-Murray-Nativis.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/Donna-Morgan-Murray-Nativis.jpg http://www.pharmajournalist.com/synlogic-mirna-therapeutics-signs-definitive-merger/ 2017-05-18T06:08:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/helen-milton-appointed-amags-regulatory-affairs-vice-president/ 2017-05-18T06:16:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/amag-pharma-logo.png http://www.pharmajournalist.com/noxxon-pharma-signs-collaboration-nct-heidelberg/ 2017-05-18T06:20:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/noxxon-pharma.png http://www.pharmajournalist.com/concert-pharmaceuticals-announces-clinical-hold-ctp-543/ 2017-05-18T12:13:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/concert-pharmaceuticals.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/concert-pharmaceuticals.jpg http://www.pharmajournalist.com/lilly-selects-cogstate-preferred-provider-alzheimer-disease-platform/ 2017-05-18T12:16:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-grants-octapharma-orphan-drug-designation-octagam-10/ 2017-05-18T12:22:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/FDA-octapharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/FDA-octapharma.jpg http://www.pharmajournalist.com/fda-expands-approved-use-kalydeco-treat-cystic-fibrosis/ 2017-05-18T12:30:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/kalydeco-tablets.png https://pharmajournalist.com/wp-content/uploads/2017/05/kalydeco-tablets.png http://www.pharmajournalist.com/fda-approves-launch-doxorubicin-hydrochloride-liposome-injection-u-s-market/ 2017-05-18T12:42:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dr-reddy-logo.png http://www.pharmajournalist.com/cytodyns-pro-140-treats-patient-suffering-gvhd-phase-2-trial/ 2017-05-18T12:48:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Cytodyn-Logo.jpg http://www.pharmajournalist.com/aveo-oncology-appoints-matthew-dallas-cfo/ 2017-05-20T19:48:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/aveo-oncology.jpg http://www.pharmajournalist.com/kemwell-supplies-biologics-drug-substance-phase-1-clinical-trials-u-s-ind-filing/ 2017-05-20T19:53:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Kemwell-Biopharma-cGMP-Clinical-Studies.jpg http://www.pharmajournalist.com/ssb-nova-collaborates-combine-two-innovative-technologies/ 2017-05-20T19:56:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sartorius-stedim-biotech.jpg http://www.pharmajournalist.com/aduro-biotech-merck-expand-collaboration-evaluate-combination-crs-207-keytruda/ 2017-05-20T19:59:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/merck-group.jpg http://www.pharmajournalist.com/ppd-expands-vaccine-development-laboratory/ 2017-05-20T20:05:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/fda-approves-pharmadax-generic-version-seroquel-xr/ 2017-05-20T20:07:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/astellas-completes-acquisition-ogeda-sa/ 2017-05-20T20:08:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/fda-approves-jubilants-amlodipine-olmesartan-medoxomil-tablets/ 2017-05-20T20:11:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/amgen-submits-bla-fda-erenumab/ 2017-05-20T20:12:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/xoma-earns-10-million-milestone-payment-another-licensed-assets/ 2017-05-20T20:15:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/xoma-corporation.png http://www.pharmajournalist.com/acasti-pharma-invited-present-capre-study-results-national-lipid-association-scientific-sessions/ 2017-05-20T20:17:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/acasti-pharma-logo.png http://www.pharmajournalist.com/msd-submits-application-combine-dpp-4-inhibitor-sglt2-inhibitor-treatment-type-2-diabetes/ 2017-05-20T20:19:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/chmp-recommends-approve-sanofis-insulin-lispro-biosimilar/ 2017-05-22T10:12:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi.jpg http://www.pharmajournalist.com/ema-recommends-grant-oxervate-treat-neurotrophic-keratitis/ 2017-05-22T10:20:37+00:00 http://www.pharmajournalist.com/gto-appoints-kieran-walsh-president-us-operations/ 2017-05-22T14:07:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/GTO-logo.jpg http://www.pharmajournalist.com/avenue-therapeutics-receives-notice-allowance-uspto-administration-intravenous-tramadol/ 2017-05-22T14:09:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/avenue-therapeutics-logo.jpg http://www.pharmajournalist.com/new-atmp-treat-cartilage-defects-knee/ 2017-05-22T14:12:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/uspto-allowed-two-new-patent-albireo-a4250-term-2031/ 2017-05-22T14:16:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/albireo-logo.jpg http://www.pharmajournalist.com/chinese-fda-approves-clinical-trial-albumin-rice/ 2017-05-22T14:20:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pyruvate-preserves-antiglycation-defenses-porcine-brain-cardiac-arrest/ 2017-05-22T14:24:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/alphaeon-submits-bla-daewoong-botulinum-toxin/ 2017-05-22T14:26:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/vertex-pharmaceuticals-include-maxor-distribution-provider-orkambi-kalydeco/ 2017-05-22T14:36:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/maxor-pharmacy.png http://www.pharmajournalist.com/pci-biotech-rxi-pharma-extend-preclinical-research-collaboration/ 2017-05-23T08:12:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/rxi-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/rxi-pharma.jpg http://www.pharmajournalist.com/nektar-takeda-collaborates-explore-combination-cancer-therapy/ 2017-05-23T08:14:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/tekni-plex-announces-acquisition-brunaseals/ 2017-05-24T12:31:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/BrunaSeals-LUXESEAL.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/BrunaSeals-LUXESEAL.jpg http://www.pharmajournalist.com/worldwide-clinical-trials-appoints-karen-nowatkoski-clinical-operations-vp/ 2017-05-24T12:42:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Karen-Nowatkoski-Vice-President-of-Clinical-Operations.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/Karen-Nowatkoski-Vice-President-of-Clinical-Operations.jpg http://www.pharmajournalist.com/cros-nt-extend-medidata-pact-deploy-medidatas-next-gen-edc-rtsm-systems/ 2017-05-24T12:47:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/cros-nt-logo.jpg http://www.pharmajournalist.com/palladio-biosciences-acquires-global-rights-develop-lixivaptan/ 2017-05-24T14:54:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/palladio-logo.png http://www.pharmajournalist.com/debiopharm-international-acquires-clinical-stage-adc-immunogens-imgn529debio-1562/ 2017-05-24T15:02:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/debiopharm-group-logo.jpg http://www.pharmajournalist.com/atox-bio-reltecimod-passes-futility-analysis-will-continue-phase-3/ 2017-05-24T15:29:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/gb-sciences-files-patent-application-chronic-pain-heart-therapies-based-mccm/ 2017-05-24T15:34:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Dr.-Andrea-Small-Howard.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/Dr.-Andrea-Small-Howard.jpg http://www.pharmajournalist.com/astrazeneca-sells-seloken-european-rights-recordati/ 2017-05-24T15:36:11+00:00 http://www.pharmajournalist.com/astrazenecas-bydureon-exscel-trial-meets-primary-safety-objective-type-2-diabetes-patients/ 2017-05-24T15:38:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/lsne-contract-manufacturing-selecta-biosciences-signs-manufacturing-supply-agreement/ 2017-05-25T12:33:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/LSNE-Contact-Manufacturing.jpg http://www.pharmajournalist.com/pierre-fabre-acquires-igenica-biotherapeutics-immuno-oncology/ 2017-05-25T12:38:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Pierre-Fabre-logo.png http://www.pharmajournalist.com/selexis-sa-ose-immunotherapeutics-signs-agreement-development-oses-interleukin-receptor-7-antagonist/ 2017-05-25T12:41:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/selexis-logo.jpg http://www.pharmajournalist.com/kbi-biopharma-invests-30m-expansion-projects-durham-boulder-sites/ 2017-05-25T12:43:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/kbi-biopharma.jpg http://www.pharmajournalist.com/hebron-technology-wins-design-implementation-project-bid-tianjin-chas-esun/ 2017-05-25T12:46:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/chase-sun-logo.jpg http://www.pharmajournalist.com/sun-pharma-announces-us-fda-filing-acceptance-bla-tildrakizumab/ 2017-05-25T12:50:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/intellipharma-reports-par-pharma-additional-strengths-launch-generic-focalin-xr/ 2017-05-25T12:53:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/miragen-therapeuticss-mrg-106-receives-eu-orphan-medicinal-product-designation/ 2017-05-25T12:55:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/miragen-therapeutics.jpg http://www.pharmajournalist.com/trialscope-launches-second-global-clinical-trial-disclosure-maturity/ 2017-05-25T12:58:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/akebia-therapeutics-appoints-rita-jain-svp-cmo/ 2017-05-27T20:18:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/akebia-pharma-logo.png http://www.pharmajournalist.com/pharmamar-signs-licensing-agreement-eczacibasi-group-aplidin/ 2017-05-27T20:23:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/PharmaMar.jpg http://www.pharmajournalist.com/optum-merck-collaborate-explore-obrsas-performance-models/ 2017-05-27T20:29:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/optum.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/optum.jpg http://www.pharmajournalist.com/constellation-pharmaceuticals-appoints-jigar-raythatha-president-ceo/ 2017-05-27T20:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Constellation-Pharmaceuticals-Jigar-Raythatha.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/Constellation-Pharmaceuticals-Jigar-Raythatha.jpg http://www.pharmajournalist.com/fda-accepted-bristol-myers-squibb-supplemental-bla-use-opdivo/ 2017-05-27T20:39:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/x4-pharmaceuticals-announces-study-x4p-001-patients-advanced-ccrcc/ 2017-05-27T20:43:52+00:00 http://www.pharmajournalist.com/ammonett-pharma-receives-notice-allowance-u-s-patent-detecting-treating-ghd/ 2017-05-27T20:45:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/us-fda-odac-recommends-approval-pizers-epoetin-alfa-biosimilar-across-indications/ 2017-05-27T20:47:55+00:00 http://www.pharmajournalist.com/hovione-initiate-hy02-phase-1-clinical-trial/ 2017-05-31T14:28:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/avista-pharma-mmrf-partners-produce-conjugate-vaccine-combat-substance-abuse/ 2017-05-31T14:30:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/avista-pharma-solutions.jpg http://www.pharmajournalist.com/recipharm-appoints-shabbir-mostafa-director-business-management-uk-ireland/ 2017-05-31T14:32:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/recipharm-logo.jpg http://www.pharmajournalist.com/compugen-appoints-dr-michal-preminger-board-directors/ 2017-05-31T14:36:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/compugen-logo.jpg http://www.pharmajournalist.com/bluebee-medisapiens-enters-partnership-provide-comprehensive-integrated-solution-ngs/ 2017-05-31T14:38:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/MediSapiens-logo.jpg http://www.pharmajournalist.com/biopharma-services-completes-3-fda-inspections-research-centers/ 2017-05-31T14:41:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/biopharma-services-inc.jpg http://www.pharmajournalist.com/taigen-biotechnology-submits-nda-taigexyn-intravenous-formulation-cfda/ 2017-05-31T14:43:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/optibrium-imperial-college-collaborate-drug-development-neglected-diseases-part-project-dndi/ 2017-05-31T14:45:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/optibrium-logo.png http://www.pharmajournalist.com/us-fda-granted-odd-abeonas-eb-101-gene-therapy-program/ 2017-05-31T14:47:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/uspto-issues-notice-allowance-neurana-pharmaceuticals-two-new-tolperisone-patents/ 2017-05-31T14:48:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/lysogene-collaborates-brammer-bio-produce-lys-gm101/ 2017-05-31T14:50:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lysogene-logo.jpg http://www.pharmajournalist.com/lysogene-completes-enrollment-samos/ 2017-05-31T14:51:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lysogene-logo.jpg http://www.pharmajournalist.com/astrazeneca-appoints-professor-nazneen-rahman-board-directors-science-committee/ 2017-05-31T15:27:39+00:00 http://www.pharmajournalist.com/new-research-delaying-onset-motor-neurone-disease-shows-positive-results/ 2017-05-31T15:34:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Motor-Neuron.gif https://pharmajournalist.com/wp-content/uploads/2017/05/Motor-Neuron.gif http://www.pharmajournalist.com/synthetic-genomics-launches-cgmp-suite/ 2017-06-01T15:36:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/sgvi-lab.jpg http://www.pharmajournalist.com/eisai-johns-hopkins-extend-drug-discovery-collaboration-new-licensing-agreement/ 2017-06-01T15:38:37+00:00 http://www.pharmajournalist.com/ligand-announces-aziyo-biologics-acquires-commercial-products-partner-cormatrix/ 2017-06-01T15:41:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ligand-pharmaceuticals.png http://www.pharmajournalist.com/array-biopharma-bristol-myers-squibb-announce-strategic-collaboration/ 2017-06-01T15:42:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/ligand-enters-worldwide-omniab-platform-license-agreement-xcella-biosciences/ 2017-06-01T15:44:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ligand-pharmaceuticals.png http://www.pharmajournalist.com/roche-announces-fda-approval-companion-diagnostic-identify-alk-positive-non-small-cell-lung-cancer-patients/ 2017-06-01T15:49:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Non-small-cell-lung-cancer-tissue.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/Non-small-cell-lung-cancer-tissue.jpg http://www.pharmajournalist.com/lonza-acquires-cell-gene-contract-manufacturer-pharmacell/ 2017-06-01T15:54:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Lonza.jpg http://www.pharmajournalist.com/tom-privette-joins-acurian-vp-head-global-business-development/ 2017-06-01T16:15:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/mylan-announces-launch-generic-azilect-tablets/ 2017-06-02T12:22:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-pharma.jpg http://www.pharmajournalist.com/biocryst-reports-additional-positive-results-second-interim-analysis-apex-1-trial/ 2017-06-02T12:26:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biocryst-pharma.jpg http://www.pharmajournalist.com/obi-pharma-announces-acquisition-th-3424-threshold-pharmaceuticals/ 2017-06-02T12:29:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/threshold-pharmaceuticals-logo.jpg http://www.pharmajournalist.com/kd-pharma-group-invests-nutriceutical-holdings/ 2017-06-02T12:32:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/KD-Pharma-Group-Logo.png http://www.pharmajournalist.com/sylentis-initiates-phase-iii-study-treatment-dry-eye-syndrome/ 2017-06-02T12:46:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/pharmamar.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/pharmamar.jpg http://www.pharmajournalist.com/jazz-pharmaceuticals-announces-fda-acceptance-nda-vyxeos/ 2017-06-02T12:49:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/aequus-cdrd-improve-cannabinoid-based-therapeutics/ 2017-06-02T13:02:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/cannabinoid-based-therapeutics.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/cannabinoid-based-therapeutics.jpg http://www.pharmajournalist.com/sanofi-regeneron-present-positive-study-results-investigational-pd-1-antibody-regn2810/ 2017-06-06T07:20:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi.jpg http://www.pharmajournalist.com/bristol-myers-squibb-qiagen-sign-agreement-use-ngs-technology/ 2017-06-06T07:21:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/kamada-announces-appointment-michal-stein-m-d-vice-president-medical-director/ 2017-06-06T07:26:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/kamada-logo.png http://www.pharmajournalist.com/essa-pharma-presents-data-phase-1-trial-epi-506-2017-asco-annual-meeting/ 2017-06-06T07:44:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/ESSA-Logo.jpg http://www.pharmajournalist.com/braeburn-pharmaceuticals-appoints-michael-m-derkacz-president-ceo/ 2017-06-06T07:48:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Michael-M.-Derkacz-President-and-CEO.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/Michael-M.-Derkacz-President-and-CEO.jpg http://www.pharmajournalist.com/cornerstone-pharmaceuticals-announces-corporate-name-change-rafael-pharmaceuticals/ 2017-06-06T10:05:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Rafael-pharma-logo.png http://www.pharmajournalist.com/biocryst-announces-rapivab-pediatric-snda-acceptance/ 2017-06-06T10:08:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biocryst-pharma-logo.jpg http://www.pharmajournalist.com/nih-researchers-find-potential-genetic-cause-cushing-syndrome/ 2017-06-06T10:20:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/NIH-pituitary-gland.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/NIH-pituitary-gland.jpg http://www.pharmajournalist.com/novartis-drug-tasigna-receives-eu-approval-inclusion-tfr-data-product-label/ 2017-06-06T10:27:04+00:00 http://www.pharmajournalist.com/veloxis-announces-agreement-chiesi-commercialize-envarsus-xr-china/ 2017-06-07T14:54:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Veloxis-Pharma-Logo.jpg http://www.pharmajournalist.com/pfizer-receives-fda-fast-track-designation-tafamidis-transthyretin-cardiomyopathy/ 2017-06-07T14:54:59+00:00 http://www.pharmajournalist.com/astrazeneca-enters-agreement-grunenthal-divest-rights-migraine-treatment-zomig/ 2017-06-08T11:55:34+00:00 http://www.pharmajournalist.com/abbvies-rheumatoid-arthritis-drug-succeeds-trial/ 2017-06-08T11:56:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/allergan-acquire-keller-medical-inc/ 2017-06-08T11:58:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/allergan.jpg http://www.pharmajournalist.com/lundbeck-obtains-rights-breakthrough-research-alzheimers-disease/ 2017-06-08T12:01:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/lundbeck-logo.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/lundbeck-logo.jpg http://www.pharmajournalist.com/aptuit-announces-strategic-provider-agreement-regulus-therapeutics/ 2017-06-08T12:11:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/regulus-therapeutics.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/regulus-therapeutics.jpg http://www.pharmajournalist.com/tekni-plex-announces-15-million-investment-new-china-manufacturing-facility/ 2017-06-08T12:16:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Tekniplex.jpg http://www.pharmajournalist.com/valeant-announces-sale-inova-pharmaceuticals-930-million/ 2017-06-08T12:18:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/valeant-pharma.jpg http://www.pharmajournalist.com/lilly-announces-strategic-collaboration-keybioscience/ 2017-06-08T12:20:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/olon-spa-announces-acquisition-ricerca-biosciences-chemical-division-ohio/ 2017-06-09T17:06:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/olonspa-logo.jpg http://www.pharmajournalist.com/kleo-pharmaceuticals-appoints-douglas-j-manion-m-d-ceo/ 2017-06-09T17:10:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/kleo-logo.png http://www.pharmajournalist.com/midatech-pharma-signs-agreement-novartis-oncology-compound-panobinostat/ 2017-06-09T17:17:34+00:00 http://www.pharmajournalist.com/new-treatment-hope-women-brca1-breast-cancers/ 2017-06-09T17:26:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Australian-researchers_Pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/Australian-researchers_Pharma.jpg http://www.pharmajournalist.com/numerate-takeda-enter-agreement-generate-novel-clinical-candidates-using-ai-driven-drug-discovery/ 2017-06-13T15:21:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/eurofins-announces-acquisition-alphora-research-inc/ 2017-06-13T15:25:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Eurofins.png http://www.pharmajournalist.com/sanofi-regeneron-announce-positive-results-first-dedicated-studies-evaluating-praluent/ 2017-06-13T15:27:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi.jpg http://www.pharmajournalist.com/astellas-pfizer-announce-amendment-clinical-research-protocol-phase-3-prosper-trial-enzalutamide/ 2017-06-13T15:30:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/numab-therapeutics-announces-collaboration-option-agreement-kaken-pharma/ 2017-06-14T07:35:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Kaken-Pharma.jpg http://www.pharmajournalist.com/pfizer-lilly-receive-fda-fast-track-designation-tanezumab/ 2017-06-14T07:36:35+00:00 http://www.pharmajournalist.com/certain-genetic-faults-help-predict-success-immunotherapy/ 2017-06-14T07:40:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/dna_flikr_cc_by_2.0_andy_leppard.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/dna_flikr_cc_by_2.0_andy_leppard.jpg http://www.pharmajournalist.com/selexis-teneobio-team-advance-development-uniabs-targeting-cancer/ 2017-06-14T07:44:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/selexis-logo.jpg http://www.pharmajournalist.com/leo-pharma-starts-phase-3-clinical-study-tralokinumab-atopic-dermatitis/ 2017-06-15T06:19:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/arena-pharmaceuticals-appoints-jennifer-jarrett-board-directors/ 2017-06-15T06:27:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/ARENA-Pharmaceuticals.png http://www.pharmajournalist.com/generon-announces-initiation-phase-1-clinical-trial-337/ 2017-06-15T06:32:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/pfizer-receives-commercialization-rights-europe-cresemba/ 2017-06-15T06:36:14+00:00 http://www.pharmajournalist.com/axcella-appoints-tony-tramontin-svp-chief-scientific-officer/ 2017-06-15T06:46:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/axcella.png http://www.pharmajournalist.com/probiodrug-announces-encouraging-results-phase-2a-saphir-study/ 2017-06-15T06:56:22+00:00 http://www.pharmajournalist.com/sgs-expands-extractables-leachables-testing-capabilities-shanghai-facility/ 2017-06-15T07:01:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/sgs-logo.jpg http://www.pharmajournalist.com/jsr-life-sciences-agrees-acquire-selexis-sa/ 2017-06-15T07:11:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/JSR-Life-Sciences-logo.jpg http://www.pharmajournalist.com/baxter-announces-agreement-dorizoe-lifesciences-expand-generic-injectables-pipeline/ 2017-06-15T07:15:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/baxter.jpg http://www.pharmajournalist.com/lannett-announces-approval-amantadine-hydrochloride-capsules-usp-100-mg/ 2017-06-19T12:52:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/fda-accepts-rigels-new-drug-application-tavalisse/ 2017-06-19T12:59:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/johnson-johnson-announces-completion-acquisition-actelion/ 2017-06-19T13:01:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/johnson-Johnson.jpg http://www.pharmajournalist.com/boehringer-presents-phase-iii-results-adalimumab-biosimilar-candidate-humira/ 2017-06-19T13:02:13+00:00 http://www.pharmajournalist.com/navidea-enters-exclusive-license-distribution-agreement-india-sayre-therapeutics/ 2017-06-20T17:59:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/navidea-biopharmaceuticals-logo.jpg http://www.pharmajournalist.com/nanosphere-health-sciences-signs-binding-merger-agreement-100-acquisition-corazon-gold-corp/ 2017-06-20T18:02:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/nanosphere-health-sciences.jpg http://www.pharmajournalist.com/blackthorn-receives-8-million-advance-kor-antagonist-program/ 2017-06-20T18:09:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/blackthorn-therapeutics-logo.jpg http://www.pharmajournalist.com/nanotherapeutics-appoints-peter-h-khoury-president-ceo/ 2017-06-20T18:17:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/nanotherapeutics-inc.png http://www.pharmajournalist.com/innocrin-pharmaceuticals-granted-sme-status-designation-ema/ 2017-06-20T18:20:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/gsk-wins-235-million-teva-coreg-patent-trial/ 2017-06-22T05:50:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/seqirus-announces-next-major-advancement-cell-based-influenza-vaccine-technology/ 2017-06-22T05:53:20+00:00 http://www.pharmajournalist.com/almac-discovery-debiopharm-international-sa-announce-licensing-agreement/ 2017-06-22T06:03:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/smithers-avanza-adds-three-additional-instruments-bioanalytical-laboratory/ 2017-06-22T06:08:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/smithers-avanza.jpg http://www.pharmajournalist.com/median-medidata-partner-deliver-differentiated-image-management-services-clinical-trials/ 2017-06-22T06:12:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/cancer-research-uk-sets-latest-20m-grand-challenges-beat-cancer-sooner/ 2017-06-22T06:19:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/cancer-research-uk.png http://www.pharmajournalist.com/discovery-guide-immunotherapy-lung-cancer/ 2017-06-22T06:23:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/cell-lung-cancer.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/cell-lung-cancer.jpg http://www.pharmajournalist.com/novo-nordisk-says-obesity-drug-helps-13-8-percent-weight-loss-phase-2-trial/ 2017-06-25T00:39:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/enanta-announces-abbvie-receives-chmp-positive-opinion-maviret/ 2017-06-25T00:40:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/eisai-ewopharma-announce-commercial-partnership/ 2017-06-25T00:42:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/collaboration.png http://www.pharmajournalist.com/durect-completes-enrollment-persist-phase-3-trial-posimir/ 2017-06-25T00:44:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/durect-logo.jpg http://www.pharmajournalist.com/aveo-oncology-announces-positive-chmp-opinion-tivozanib-treatment-advanced-renal-cell-carcinoma/ 2017-06-25T00:48:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/aveo-oncology.jpg http://www.pharmajournalist.com/neurovive-yungjin-pharm-start-clinical-development-genetic-mitochondrial-disease/ 2017-06-28T09:07:47+00:00 http://www.pharmajournalist.com/breckenridge-pharmaceutical-announces-final-anda-approval-azacitidine-injection/ 2017-06-28T09:09:10+00:00 http://www.pharmajournalist.com/lifearc-dstl-cdrd-collaborate-identify-antibacterial-drug-targets/ 2017-06-28T11:08:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/lifearc.jpg http://www.pharmajournalist.com/allergan-introduces-refresh-optive-mega-3-enhanced-flaxseed-oil/ 2017-06-28T11:12:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/allergan.jpg http://www.pharmajournalist.com/qs-pharma-receives-approval-ema-commercial-manufacture/ 2017-06-28T11:17:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/quotient-clinical.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/quotient-clinical.jpg http://www.pharmajournalist.com/santhera-selects-veeva-crm-opendata-commercial-software-data-platform/ 2017-06-28T11:21:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Veeva-CRM.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/Veeva-CRM.jpg http://www.pharmajournalist.com/casebia-therapeutics-names-robin-walker-vp-head-legal/ 2017-06-28T11:27:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/RobinWalker-Casebia.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/RobinWalker-Casebia.jpg http://www.pharmajournalist.com/trovagene-announces-manufacturing-agreement-nerpharma-supply-pcm-075-aml-trial/ 2017-06-30T07:41:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Trovagene-office-headquaters.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/Trovagene-office-headquaters.jpg http://www.pharmajournalist.com/valeant-pharmaceuticals-completes-sale-dendreon-sanpower-group/ 2017-06-30T07:43:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/valeant-pharma.jpg http://www.pharmajournalist.com/cordenpharma-ge-healthcare-offer-unique-end-end-solution-accelerate-oligonucleotide-drug-development/ 2017-06-30T07:46:09+00:00 http://www.pharmajournalist.com/bioverativ-completes-acquisition-true-north-therapeutics/ 2017-06-30T07:49:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/true-north-therapeutics-logo.png http://www.pharmajournalist.com/glytec-receives-five-additional-patent-allowances-diabetes-therapy-management-software/ 2017-06-30T07:52:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Patent_Image.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/Patent_Image.jpg http://www.pharmajournalist.com/fda-approves-vns-therapy-treatment-drug-resistant-epilepsy-children-young-four-years-old/ 2017-06-30T07:55:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/zydus-starts-phase-ii-trial-zyan1-treating-anemia-patients-ckd/ 2017-07-06T06:13:05+00:00 http://www.pharmajournalist.com/wp-content/uploads/2017/07/zydus-biologics-300x223.jpg http://www.pharmajournalist.com/sun-pharma-samsung-biologics-announce-strategic-manufacturing-tie-tildrakizumab/ 2017-07-06T06:15:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/endo-completes-divestiture-litha-healthcare-group/ 2017-07-06T06:18:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/endo-logo.png http://www.pharmajournalist.com/exscientia-enters-strategic-drug-discovery-collaboration-gsk/ 2017-07-06T06:19:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/arbor-pharmaceuticals-llc-debiopharm-international-sa-announce-u-s-fda-approval-triptodur/ 2017-07-06T06:22:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/arbor-pharma-logo.jpg http://www.pharmajournalist.com/fda-grants-sobi003-orphan-drug-designation-treatment-mps-iiia/ 2017-07-06T06:36:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/biodelivery-sciences-signs-exclusive-agreement-purdue-pharma-canada/ 2017-07-13T11:28:00+00:00 http://www.pharmajournalist.com/sanofi-acquire-protein-sciences/ 2017-07-13T11:29:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi.jpg http://www.pharmajournalist.com/cure-pharmaceutical-therapix-biosciences-signs-mou-israels-assuta-medical-center/ 2017-07-13T11:30:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/cure-pharmaceutical-logo.png http://www.pharmajournalist.com/abzena-obi-pharma-sign-thiobridge-licence-agreement/ 2017-07-13T11:32:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/inmed-pharmaceuticals-signs-rd-agreement-atera/ 2017-07-13T11:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/eurofins-signed-exclusive-agreement-acquire-amatsigroup/ 2017-07-13T11:35:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Eurofins.png http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-allena-pharmaceuticals-investigational-therapy-treatment-primary-hyperoxaluria/ 2017-07-17T06:08:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/shangpharma-innovation-university-california-san-francisco-announce-strategic-research-collaboration/ 2017-07-17T06:09:59+00:00 http://www.pharmajournalist.com/fda-grants-fast-track-designation-vt-1598-treatment-valley-fever/ 2017-07-17T06:10:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/new-improved-bnf-bnfc-app-launched/ 2017-07-17T06:14:37+00:00 http://www.pharmajournalist.com/lannett-receives-approval-cyproheptadine-hydrochloride-syrup-2-mg5-ml/ 2017-07-17T06:17:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/biognosys-raises-new-funds-bring-proteomics-life-science-research-market/ 2017-07-17T06:23:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/biognosys.jpg http://www.pharmajournalist.com/lilly-reaches-settlement-agreement-u-s-cialis-patent-litigation/ 2017-07-17T06:25:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/glenmark-pharmaceuticals-enters-exclusive-agreement-cyndea-pharma/ 2017-07-19T15:00:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/glenmark-pharma.jpg http://www.pharmajournalist.com/valeant-agrees-sell-obagi-medical-products-business/ 2017-07-19T15:05:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/valeant-pharma.jpg http://www.pharmajournalist.com/amgen-ucb-provide-update-regulatory-status-evenity-us/ 2017-07-19T15:08:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/roches-ocrevus-approved-relapsing-primary-progressive-multiple-sclerosis-australia/ 2017-07-19T15:10:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/sta-pharmaceutical-signs-supply-agreement-tesaro/ 2017-07-25T06:22:33+00:00 http://www.pharmajournalist.com/boehringer-ingelheim-breaks-ground-217-million-expansion-fremont-california-manufacturing-facility/ 2017-07-25T06:23:39+00:00 http://www.pharmajournalist.com/takeda-schrodinger-announce-multi-year-multi-target-research-collaboration/ 2017-07-25T06:25:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/pfizer-completes-license-agreement-exclusive-commercialization-rights-europe-cresemba-isavuconazole/ 2017-07-25T06:26:47+00:00 http://www.pharmajournalist.com/modgene-pharma-announces-issuance-us-patent-alzheimers-disease-prevention/ 2017-07-25T06:28:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/modgene-pharma-llc.png http://www.pharmajournalist.com/oncology-venture-novartis-pharma-enter-agreement/ 2017-07-25T06:29:51+00:00 http://www.pharmajournalist.com/brainstorm-awarded-16-million-grant-support-phase-3-clinical-trial-nurown-als/ 2017-07-25T06:39:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/biolight-reports-successful-results-phase-12a-clinical-trial-glaucoma-insert/ 2017-07-25T06:46:42+00:00 http://www.pharmajournalist.com/collidion-acquires-80-stake-plex-pharmaceuticals/ 2017-08-03T08:56:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/takeda-cardurion-pharmaceuticals-launch-cardiovascular-development-partnership/ 2017-08-03T08:57:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/achieve-life-sciences-announces-closing-merger-oncogenex-pharmaceuticals/ 2017-08-03T08:58:04+00:00 http://www.pharmajournalist.com/sio2-medical-products-sanaria-sign-agreement-cryogenic-vials-pfspz-vaccine-prevent-malaria/ 2017-08-03T08:58:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/generex-announces-collaboration-merck-evaluate-keytruda-pembrolizumab/ 2017-08-03T09:00:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/merck-group.jpg http://www.pharmajournalist.com/zoetis-completes-acquisition-nexvet-biopharma/ 2017-08-03T09:01:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/zoetis-logo.jpg http://www.pharmajournalist.com/abbvies-drug-types-hepatitis-c-wins-eu-approval/ 2017-08-03T09:03:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/cytrx-corporation-announces-global-strategic-license-nantcell-inc/ 2017-08-03T09:04:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/otsuka-pharmaceutical-announces-acquisition-rapidly-growing-plant-based-food-innovator-daiya/ 2017-08-03T09:05:38+00:00 http://www.pharmajournalist.com/baxter-international-completes-acquisition-claris-injectables/ 2017-08-03T09:06:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/baxter.jpg http://www.pharmajournalist.com/astrazeneca-merck-establish-strategic-oncology-collaboration/ 2017-08-03T09:07:26+00:00 http://www.pharmajournalist.com/jazz-pharmaceuticals-xl-protein-gmbh-enter-license-agreement-pasylation-technology/ 2017-08-03T09:08:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/takeda-pharmaceutical-biosurfaces-announce-joint-research-program/ 2017-08-03T09:09:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/flex-pharma-launches-als-phase-2-study-flx-787-us/ 2017-08-03T09:11:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/qs-pharma-receives-approval-ema-commercial-manufacture-2/ 2017-08-03T09:16:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/03/news.jpg http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-omeros-oms721-treatment-iga-nephropathy/ 2017-08-06T22:43:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/takeda-molecular-templates-announce-multi-target-research-licensing-collaboration/ 2017-08-06T22:46:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/bristol-myers-squibb-acquire-ifm-therapeutics/ 2017-08-06T22:47:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/nexus-pharmaceuticals-receives-fda-approval-isoproterenol-hydrochloride-injection-usp/ 2017-08-06T22:50:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/nexus-pharma.png https://pharmajournalist.com/wp-content/uploads/2017/08/nexus-pharma.png http://www.pharmajournalist.com/hitgen-leo-pharma-enter-research-collaboration/ 2017-08-08T08:13:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/charles-river-laboratories-acquires-brains-line/ 2017-08-08T08:15:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/soin-neuroscience-signs-drug-development-deal-non-addicting-pain-killer/ 2017-08-10T11:38:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Soin-Neuroscience-drug-development.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/Soin-Neuroscience-drug-development.jpg http://www.pharmajournalist.com/pharmamar-starts-quadruple-combination-study-aplidin-treatment-multiple-myeloma/ 2017-08-10T11:42:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/PharmaMar_Image.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/PharmaMar_Image.jpg http://www.pharmajournalist.com/avara-pharmaceutical-services-acquires-sterile-facility-pfizer-italy/ 2017-08-10T11:51:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/avara-pharmaceutical-services.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/avara-pharmaceutical-services.jpg http://www.pharmajournalist.com/takeda-announces-alliance-stanford-university-drive-therapeutic-discoveries/ 2017-08-15T23:56:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/oxford-biomedica-announces-2-million-two-year-collaboration-co-funded-innovate-uk/ 2017-08-16T00:01:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/oxford-biomedica.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/oxford-biomedica.jpg http://www.pharmajournalist.com/array-biopharma-appoints-curtis-oltmans-general-counsel/ 2017-08-16T00:05:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Curtis-Oltmans-Arrya-Biopharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/Curtis-Oltmans-Arrya-Biopharma.jpg http://www.pharmajournalist.com/adents-obtains-gateway-provider-certification-emvo/ 2017-08-16T00:09:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/adents.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/adents.jpg http://www.pharmajournalist.com/regeneron-discontinue-development-suptavumab-respiratory-syncytial-virus/ 2017-08-16T00:13:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/jounce-therapeutics-names-hugh-cole-chief-business-officer-head-corporate-development/ 2017-08-16T00:21:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/jounce-therapeutics.png http://www.pharmajournalist.com/shire-submits-lifitegrast-marketing-authorization-application-treatment-dry-eye-disease-europe/ 2017-08-18T06:10:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/shire-pharmaceuticals.jpg http://www.pharmajournalist.com/johnson-johnson-announces-partnership-csir-imtech-develop-innovative-new-tuberculosis-treatments/ 2017-08-18T06:12:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/johnson-Johnson.jpg http://www.pharmajournalist.com/valeant-receives-fda-confirmation-vai-inspection-classification-tampa-facility/ 2017-08-18T06:24:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/valeant-pharma.jpg http://www.pharmajournalist.com/hikma-announces-new-licensing-agreement-takeda/ 2017-08-18T06:30:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Hikma-Pharma-PLC.png http://www.pharmajournalist.com/samsung-bioepis-takeda-sign-strategic-collaboration-agreement/ 2017-08-22T04:55:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/medivir-licenses-exclusive-rights-miv-802-greater-china-ascletis/ 2017-08-22T04:58:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Medivir-AB.png https://pharmajournalist.com/wp-content/uploads/2017/08/Medivir-AB.png http://www.pharmajournalist.com/teva-announces-exclusive-launch-generic-axiron-united-states/ 2017-08-22T05:01:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/champions-oncology-collaborate-alcmi-develop-unique-cohort-pdx-models/ 2017-08-22T05:06:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/champions-oncology-inc-logo.png http://www.pharmajournalist.com/pfizer-receives-u-s-fda-approval-besponsa-inotuzumab-ozogamicin/ 2017-08-22T05:10:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/ethris-astrazeneca-medimmune-develop-mrna-therapies-respiratory-diseases/ 2017-08-22T05:30:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/viracyte-announces-positive-phase-2-trial-results/ 2017-08-24T07:09:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/fda-grants-priority-review-genentechs-emicizumab-hemophilia-inhibitors/ 2017-08-24T07:11:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/otsuka-mylan-announce-license-agreement-commercialize-delamanid-deltyba/ 2017-08-24T07:18:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-pharma.jpg http://www.pharmajournalist.com/labcyte-sengine-precision-medicine-collaborate-offer-functional-drug-screening-oncology/ 2017-08-31T13:48:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/SEngine-Precision-Med.png http://www.pharmajournalist.com/wp-content/uploads/2017/08/SEngine-Precision-Med.png http://www.pharmajournalist.com/fda-approval-brings-first-gene-therapy-united-states/ 2017-08-31T13:49:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/daiichi-sankyo-enters-worldwide-licensing-agreement-boston-pharmaceuticals/ 2017-08-31T13:51:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/alimera-sciences-signs-agreement-exclusive-distributor-iluvien-france/ 2017-08-31T13:54:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Alimera-Sciences-Logo.jpg http://www.pharmajournalist.com/gilead-sciences-acquire-kite-pharma-11-9-billion/ 2017-08-31T13:55:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gilead.jpg http://www.pharmajournalist.com/kedrion-biopharma-kamada-receive-fda-approval-kedrab/ 2017-08-31T13:56:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-grants-priority-review-genentechs-gazyva-previously-untreated-follicular-lymphoma/ 2017-08-31T13:58:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/cambrex-expand-high-point-nc-facility/ 2017-08-31T14:03:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/cambrex-logo.png http://www.pharmajournalist.com/thermo-fisher-scientific-completes-acquisition-patheon/ 2017-08-31T14:05:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/sanofi-receives-tentative-fda-approval-admelog-insulin-lispro-injection-100-unitsml/ 2017-09-07T09:19:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi.jpg http://www.pharmajournalist.com/bristol-myers-squibb-completes-acquisition-ifm-therapeutics/ 2017-09-08T08:26:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/project-als-amylyx-enter-collaboration-test-amx0035/ 2017-09-08T08:28:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/project-als-logo.jpg http://www.pharmajournalist.com/immune-therapeutics-inc-announces-exclusive-agreement-sale-lodonal-kenya/ 2017-09-08T08:31:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/immune-therapeutics-logo.jpg http://www.pharmajournalist.com/alcami-establish-active-pharmaceutical-ingredient-center-excellence-germantown-wisconsin/ 2017-09-08T08:34:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/alcami-logo.jpg http://www.pharmajournalist.com/roche-presents-data-global-phase-iii-alur-study/ 2017-09-08T08:43:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/midatech-submits-mtd201-cta-filing-first-human-study-carcinoid-cancer-acromegaly/ 2017-09-08T08:46:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/midatech-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/midatech-pharma.jpg http://www.pharmajournalist.com/teva-announces-sale-paragard-intrauterine-copper-contraceptive-coopersurgical/ 2017-09-13T06:53:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/teva-pharma.jpg http://www.pharmajournalist.com/hitgen-takeda-enter-dna-encoded-library-based-drug-discovery-research-collaboration/ 2017-09-13T06:54:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/alcami-announces-grand-opening-st-louis-missouri-facility-cortex-innovation-community/ 2017-09-13T07:04:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/St.-Louis-Missouri-Facility.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/St.-Louis-Missouri-Facility.jpg http://www.pharmajournalist.com/irx-therapeutics-reports-positive-irx-2-phase-2a-head-neck-squamous-cell-carcinoma-clinical-results/ 2017-09-13T07:08:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/bioverativ-bicycle-therapeutics-develop-therapies-hemophilia-sickle-cell-disease/ 2017-09-13T07:14:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Bicycle-Therapeutics.jpg http://www.pharmajournalist.com/kura-oncology-announces-positive-phase-2-study-tipifarnib-hras-mutant-head-neck-cancer/ 2017-09-13T07:15:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/path-boosts-leadership-developing-introducing-urgently-needed-vaccines/ 2017-09-13T07:18:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/path-logo.jpg http://www.pharmajournalist.com/vanderbilt-bayer-collaborate-develop-new-therapies-kidney-diseases/ 2017-09-13T07:21:32+00:00 http://www.pharmajournalist.com/natus-acquire-neurosurgery-assets-integra-lifesciences-enters-neurosurgery-market/ 2017-09-13T07:25:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/natus-logo.jpg http://www.pharmajournalist.com/gsk-exercises-option-spear-t-cell-therapy-program-targeting-ny-eso/ 2017-09-13T07:28:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/merck-set-join-forces-project-data-sphere-pioneer-global-oncology-big-data-alliance/ 2017-09-13T07:31:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/GOBDA-MOU-signing-01.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/09/GOBDA-MOU-signing-01.jpg http://www.pharmajournalist.com/bristol-myers-squibb-halozyme-enter-global-collaboration-license-agreement/ 2017-09-15T13:04:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/ambry-genetics-announces-integration-fdna-advance-precision-medicine/ 2017-09-15T13:07:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/ambry-Genetics.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/ambry-Genetics.jpg http://www.pharmajournalist.com/agilent-obtains-u-s-fda-approval-genetisure-dx-postnatal-assay/ 2017-09-15T13:08:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/milliporesigma-expands-celonics-upstream-capabilities-mobius-single-use-bioreactors/ 2017-09-15T13:11:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/MilliporeSigma-logo.jpg http://www.pharmajournalist.com/abcellera-launches-antibody-discovery-collaboration-gsk/ 2017-09-15T13:13:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/abcellera-logo.png http://www.pharmajournalist.com/boehringer-ingelheim-receives-positive-chmp-opinion-adalimumab-biosimilar-cyltezo/ 2017-09-15T13:16:34+00:00 http://www.pharmajournalist.com/evotec-mars-innovation-establish-academic-bridge-lab150-toronto/ 2017-09-15T13:22:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/evotec-logo.jpg http://www.pharmajournalist.com/fujifilm-opens-new-cell-culture-process-development-laboratories-wilton-centre/ 2017-09-15T13:27:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Fujifilm.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/Fujifilm.jpg http://www.pharmajournalist.com/pascal-biosciences-acquires-technology-treat-leukemia-university-new-mexico/ 2017-09-15T13:30:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/pascal-biosciences-logo.png http://www.pharmajournalist.com/hanall-biopharma-harbour-biomed-develop-two-novel-biologic-therapies-greater-china/ 2017-09-15T13:34:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/hanall-biopharma-logo.jpg http://www.pharmajournalist.com/arcus-biosciences-announces-option-license-agreement-taiho-pharmaceutical/ 2017-09-20T10:22:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Arcus-Biosciences-logo.png http://www.pharmajournalist.com/absorption-systems-embarks-research-collaboration-u-s-fda/ 2017-09-20T10:24:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/eurofins-expand-presence-north-america-acquisition-eag-laboratories/ 2017-09-20T10:25:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Eurofins.png http://www.pharmajournalist.com/tsi-completes-phase-1-clinical-trial-novel-clot-dissolving-therapy-ts01/ 2017-09-20T10:27:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/regeneron-sanofi-announce-positive-study-results-dupixent/ 2017-09-20T10:29:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sanofi.jpg http://www.pharmajournalist.com/immunocore-bill-melinda-gates-foundation-collaborate-develop-immunotherapies-infectious-diseases/ 2017-09-20T10:33:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/immunocore.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/immunocore.jpg http://www.pharmajournalist.com/nus-scientists-combine-antimalarial-drug-light-sensitive-molecules-promising-treatment-cancer/ 2017-09-20T10:36:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/NUS-scientists.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/09/NUS-scientists.jpg http://www.pharmajournalist.com/astrazeneca-aspen-enter-agreement-remaining-rights-anaesthetics-medicines/ 2017-09-20T10:44:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/provention-bio-announces-licensing-agreements-janssen-two-clinical-stage-immunology-assets/ 2017-09-22T14:37:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/milliporesigma-opens-chinas-first-bioreliance-end-end-biodevelopment-center-shanghai/ 2017-09-22T14:39:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/MilliporeSigma-logo.jpg http://www.pharmajournalist.com/gsk-astrazeneca-labcyte-form-alliance-develop-acoustic-mass-spectrometry/ 2017-09-22T14:41:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/aveo-oncology-eusa-pharma-announce-tinivo-combination-study-opt/ 2017-09-22T14:42:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/aveo-oncology.jpg http://www.pharmajournalist.com/pfizer-goes-court-allow-competition-biologics-expand-options-patients/ 2017-09-22T14:53:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/recipharm-roche-sign-agreement-manufacture-range-solid-dose-products/ 2017-09-22T14:57:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/common-ear-infections-not-treated-antibiotics-says-nice/ 2017-09-22T15:02:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/child-ear-exam.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/child-ear-exam.jpg http://www.pharmajournalist.com/nivolumab-now-available-lung-cancer-company-offers-nice-new-cdf-deal/ 2017-09-22T15:06:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/NICE-Cancer-Drug-nivolumab.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/NICE-Cancer-Drug-nivolumab.jpg http://www.pharmajournalist.com/catalent-sings-agreement-acquire-cook-pharmica-950-million/ 2017-09-22T15:11:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/cook-pharmica.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/cook-pharmica.jpg http://www.pharmajournalist.com/chemotherapy-pain-eased-jetlag-drug-study-suggests/ 2017-09-22T15:14:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/amgen-simcere-co-develop-commercialize-biosimilars-china/ 2017-09-27T14:32:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/medherant-signs-agreement-leading-japanese-transdermal-patch-company/ 2017-09-27T14:35:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/medherant-drug-delivery.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/09/medherant-drug-delivery.jpg http://www.pharmajournalist.com/mallinckrodt-completes-acquisition-infacare-pharmaceutical-corporation-stannsoporfin/ 2017-09-27T14:38:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg http://www.pharmajournalist.com/teva-announces-reintroduction-generic-depo-provera-united-states/ 2017-09-27T14:40:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/teva-pharma.jpg http://www.pharmajournalist.com/ec-approves-symtuza-treatment-hiv-1-adults-adolescents-europe/ 2017-09-27T14:48:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/geisinger-boehringer-ingelheim-develop-risk-prediction-model-type-2-diabetes-health-outcomes/ 2017-09-27T14:51:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/cfda-approves-gileads-sovaldi-treatment-chronic-hepatitis-c-virus-infection/ 2017-09-27T14:55:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gilead.jpg http://www.pharmajournalist.com/genelux-initiates-phase-2-clinical-trial-gl-onc1-recurrent-ovarian-cancer/ 2017-09-28T08:53:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/astrazeneca-announces-positive-top-line-results-phase-iii-pinnacle-4-trial/ 2017-09-28T09:00:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/newlink-genetics-evaluate-io-based-combination-therapies-pancreatic-cancer/ 2017-09-28T09:05:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/NewLink-Genetics.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/09/NewLink-Genetics.jpg http://www.pharmajournalist.com/mhlw-approves-gsks-benlysta-japan-systemic-lupus-erythematosus/ 2017-10-01T00:12:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/gilead-announces-new-license-agreement-medicines-patent-pool-access-bictegravir/ 2017-10-05T07:09:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gilead.jpg http://www.pharmajournalist.com/aytu-bioscience-announces-international-distribution-agreement-fiera-japan/ 2017-10-05T07:12:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/aytu-bioscience-logo.png http://www.pharmajournalist.com/ultragenyx-acquire-dimension-therapeutics/ 2017-10-05T07:14:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Ultragenyxlogo.gif http://www.pharmajournalist.com/lonza-acquire-u-s-clinical-manufacturing-site-shire-plc/ 2017-10-05T07:16:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/mimedx-completes-divestiture-stability-biologics-subsidiary/ 2017-10-05T07:18:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/MiMedx-Group-Inc-logo.jpg http://www.pharmajournalist.com/takeda-announces-fda-approval-alunbrig-brigatinib-180-mg-tablets/ 2017-10-05T07:21:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/addf-pfizers-cti-co-fund-new-alzheimers-project/ 2017-10-05T07:23:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/transgene-randox-develop-innovative-multifunctional-oncolytic-virotherapies-solid-tumors/ 2017-10-05T07:28:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/randox-logo.jpg http://www.pharmajournalist.com/immatics-receives-funding-develop-t-cell-receptor-based-immunotherapies/ 2017-10-05T07:34:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Immatics.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/10/Immatics.jpg http://www.pharmajournalist.com/therapix-enters-agreement-catalent-pharma-solutions-thx-ts01/ 2017-10-07T20:56:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/therapix-biosciences-ltd-logo.png http://www.pharmajournalist.com/promethera-biosciences-shibuya-announce-strategic-collaboration/ 2017-10-07T20:59:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/promethera-biosciences-logo.png http://www.pharmajournalist.com/avara-pharmaceutical-sign-agreement-acquire-reims-astrazeneca-france/ 2017-10-07T21:09:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Tim-Tyson.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/Tim-Tyson.jpg http://www.pharmajournalist.com/smithers-avanza-toxicology-services-adds-peter-capozziello-director-business-development/ 2017-10-07T21:15:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Peter-Capozziello.jpg http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-kadmons-kd025-treatment-cgvhd/ 2017-10-07T21:16:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-awards-15-grants-clinical-trials-stimulate-product-development-rare-diseases/ 2017-10-07T21:23:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pfizer-launches-novel-programs-put-important-support-services-fingertips-cancer-patients/ 2017-10-07T21:25:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/amgen-cytomx-therapeutics-announce-strategic-collaboration-immuno-oncology/ 2017-10-07T21:28:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/merck-discontinues-mk-3682b-mk-3682c-development-programs/ 2017-10-07T21:36:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/piramal-pharma-solutions-announces-large-scale-expansion-api-manufacturing-facilities/ 2017-10-10T13:24:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/pirmal-logo.jpg http://www.pharmajournalist.com/parata-systems-enters-agreement-american-associated-pharmacies/ 2017-10-10T13:27:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/parata-logo.png http://www.pharmajournalist.com/ema-accepts-marketing-application-imfinzi-treat-nsclc-patients/ 2017-10-10T13:32:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/fda-grants-priority-review-gilotrif-uncommon-egfr-mutations-advanced-nsclc/ 2017-10-10T13:40:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-ansuns-experimental-drug-das181/ 2017-10-10T13:45:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-accepts-allergans-new-drug-application-ulipristal-acetate-uterine-fibroids/ 2017-10-10T13:53:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/abbvie-turnstone-announces-collaboration-viral-immunotherapies-oncology/ 2017-10-10T13:54:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/boston-biomedical-announces-orphan-drug-designation-fda-dsp-7888/ 2017-10-10T13:59:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boston-biomedical.png http://www.pharmajournalist.com/astellas-pharma-seattle-genetics-initiate-pivotal-trial-enfortumab-vedotin/ 2017-10-10T14:05:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astellas.jpg http://www.pharmajournalist.com/kaleido-biosciences-corebiome-partner-accelerate-microbiome-therapeutic-development/ 2017-10-10T14:10:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/janssen-submits-new-drug-application-fda-apalutamide-arn-509/ 2017-10-11T13:48:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/first-patient-treated-titan-pharmaceuticals-subdermal-implant-parkinsons-disease/ 2017-10-11T13:53:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TITAN-Pharma-logo.png http://www.pharmajournalist.com/izun-pharmaceuticals-announces-positive-results-phase-2-double-blind-oral-mucositis-trial/ 2017-10-11T13:56:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Izun_Pharmaceut_logo.jpg http://www.pharmajournalist.com/biotime-announces-first-patient-u-s-clinical-trial-treated-facial-volume-deficit/ 2017-10-11T13:59:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/biotime-logo.png http://www.pharmajournalist.com/milliporesigma-opens-new-life-science-center-massachusetts/ 2017-10-11T14:04:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/MilliporeSigma.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/10/MilliporeSigma.jpg http://www.pharmajournalist.com/health-canada-accepts-mithras-marketing-authorization-application-tibelia/ 2017-10-11T14:17:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/health-canada-logo.jpg http://www.pharmajournalist.com/flexion-announces-fda-approval-zilretta-osteoarthritis-oa-knee-pain/ 2017-10-11T14:22:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/flexion-therapeutics-logo.png http://www.pharmajournalist.com/pfizer-reviewing-strategic-alternatives-consumer-healthcare-business/ 2017-10-11T14:25:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/moffitt-researchers-discover-new-targets-approved-cancer-drug/ 2017-10-11T14:30:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/moffitt-Cancer-Center.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/moffitt-Cancer-Center.jpg http://www.pharmajournalist.com/sanofi-invests-e170-million-new-vaccine-production-facility-france/ 2017-10-12T11:55:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/merz-teijin-announce-partnership-bring-xeomin-incobotulinumtoxina-japan/ 2017-10-12T12:00:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merz-pharma-deutschland.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/merz-pharma-deutschland.jpg http://www.pharmajournalist.com/otsuka-lundbeck-initiates-two-phase-3-trials-brexpiprazole-patients-bipolar-disorder/ 2017-10-12T12:05:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/otsuka-europe.jpg http://www.pharmajournalist.com/acelrx-pharmaceuticals-receives-complete-response-letter-fda-dsuvia-nda/ 2017-10-12T12:09:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/AcelRx-Pharma-Logo.jpg http://www.pharmajournalist.com/world-class-life-sciences-talent-leaders-prepare-hr-innovation-summit/ 2017-10-13T06:02:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Leap-HR-Life-Sciences2018.jpg http://www.pharmajournalist.com/cordenpharma-acquires-pfizer-api-manufacturing-facility-boulder-colorado/ 2017-10-13T13:22:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/cordenpharma1.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/10/cordenpharma1.jpg http://www.pharmajournalist.com/flex-pharma-initiates-cmt-phase-2-trial-flx-787-us/ 2017-10-17T08:22:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/bristol-myers-squibb-bmy-extends-strategic-partnership-target-pharmasolutions-target-nash/ 2017-10-17T08:24:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/ionis-pharma-initiates-clinical-study-ionis-mapt-rx-patients-alzheimers-disease/ 2017-10-17T08:26:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/ionis-pharma-logo.jpg http://www.pharmajournalist.com/renflexis-latest-addition-therapeutic-drug-monitoring-miraca-life-sciences/ 2017-10-17T08:28:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/miracalife-sciences-logo.gif http://www.pharmajournalist.com/gsk-receives-prequalification-synflorix-pneumococcal-vaccine-four-dose-vial/ 2017-10-19T16:26:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/takeda-hemoshear-enter-exclusive-drug-discovery-partnership-liver-diseases/ 2017-10-19T16:29:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/fda-grants-priority-review-exelixiss-cabometyx-treat-advanced-rcc/ 2017-10-19T16:33:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/amgen-boston-childrens-hospital-enter-neuroscience-research-collaboration/ 2017-10-19T16:37:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/6-key-reasons-attend-social-media-pharmaceutical-industry/ 2017-10-20T07:25:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/introducing-9th-annual-rna-therapeutics-2018/ 2017-10-20T07:35:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/teva-announces-submission-bla-fremanezumab-u-s-fda/ 2017-10-23T11:32:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/fda-approves-gsks-shingles-vaccine-agenus-qs-21-stimulon-adjuvant/ 2017-10-23T11:53:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/astellas-universal-cells-collaborates-utilize-universal-donor-cell-technology/ 2017-10-23T11:56:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astellas.jpg http://www.pharmajournalist.com/titan-pharmaceuticals-presents-non-clinical-data-liothyronine-l-t3-implant-studies/ 2017-10-23T11:58:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TITAN-Pharma-logo.png http://www.pharmajournalist.com/tigenix-granted-orphan-drug-designation-u-s-fda-cx601/ 2017-10-23T12:02:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/tigenix-logo.jpg http://www.pharmajournalist.com/lilly-announces-72-million-investment-diabetes-manufacturing-indianapolis/ 2017-10-23T12:10:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/agenus-creates-new-cell-therapy-subsidiary-named-agentus-therapeutics/ 2017-10-23T12:17:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/agenus-inc..jpg https://pharmajournalist.com/wp-content/uploads/2017/10/agenus-inc..jpg http://www.pharmajournalist.com/merck-brings-customers-closer-gene-therapy-product-commercialization/ 2017-10-23T12:20:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/servier-cdmo-expands-chromatography-platform-normandy/ 2017-10-23T12:26:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Servier-CDMO.png https://pharmajournalist.com/wp-content/uploads/2017/10/Servier-CDMO.png http://www.pharmajournalist.com/alcami-establishes-international-sales-office-japan/ 2017-10-23T12:29:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Alcami-sales-office-japan.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/Alcami-sales-office-japan.jpg http://www.pharmajournalist.com/quotient-clinical-signs-agreement-nuformix-evaluate-cocrystal-formulations/ 2017-10-23T12:37:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/quotient-clinical-logo.png http://www.pharmajournalist.com/vetter-expand-secondary-packaging-service-capacity-meet-rising-demands/ 2017-10-23T12:39:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Vetter-VSP-facility.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/Vetter-VSP-facility.jpg http://www.pharmajournalist.com/catalent-completes-acquisition-cook-pharmica/ 2017-10-24T15:16:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Catalent-logo.png http://www.pharmajournalist.com/tigenix-granted-orphan-drug-designation-u-s-fda-cx601-2/ 2017-10-24T18:52:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/imprimis-pharmaceuticals-offer-compounded-cyclosporine-alternative-restasis/ 2017-10-24T18:59:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/imprimis-pharma-logo.png http://www.pharmajournalist.com/ortek-therapeutics-receives-fda-clearance-ecd-device/ 2017-10-25T16:24:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/ECD-Device-Ortek.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/ECD-Device-Ortek.jpg http://www.pharmajournalist.com/incyte-macrogenics-announce-global-collaboration-licensing-agreement/ 2017-10-26T13:47:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/incyte-logo.jpg http://www.pharmajournalist.com/artemis-therapeutics-appoints-brian-m-culley-ceo/ 2017-10-26T13:52:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/artemis-therapeutics-logo.jpg http://www.pharmajournalist.com/pdl-biopharma-proposes-acquire-neos-therapeutics/ 2017-10-26T13:56:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/pdl-biopharma-logo.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-biomarins-valoctocogene-roxaparvovec/ 2017-10-26T13:58:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/hear-proqr-therapeutics-rna-therapeutics-patients-cystic-fibrosis/ 2017-10-30T09:52:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/smi-social-media-pharma-driving-patient-engagement-powerful-social-strategies-technology/ 2017-10-30T09:55:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/new-2018-role-artificial-intelligence-drug-discovery/ 2017-10-30T12:29:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/medidata-expands-partnership-beigene-use-medidatas-patient-cloud-epro-solution/ 2017-10-31T06:00:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/medidata-logo.jpg http://www.pharmajournalist.com/xynomic-pharma-acquires-global-rights-boehringer-ingelheims-bi-882370/ 2017-10-31T06:48:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/lannett-celgene-enter-settlement-license-agreement-related-thalomid/ 2017-10-31T06:51:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lannett-logo.jpg http://www.pharmajournalist.com/zydus-receives-final-approval-usfda-tamoxifen-citrate-tablets-usp/ 2017-10-31T06:53:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/zydus-biologics.jpg http://www.pharmajournalist.com/charles-river-announces-expansion-vitro-oncology-services/ 2017-10-31T06:56:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/charles-river-lab.png http://www.pharmajournalist.com/evotec-tesaro-enter-strategic-partnership-discover-novel-immuno-oncology-agents/ 2017-10-31T06:59:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/abbvie-receives-fda-priority-review-elagolix/ 2017-10-31T07:03:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/saudi-fda-approves-sobis-alprolix-treatment-haemophilia-b/ 2017-10-31T07:11:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sobi.png http://www.pharmajournalist.com/novartis-submits-application-fda-kymriah-tisagenlecleucel/ 2017-10-31T07:15:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/daiichi-sankyos-enliven-phase-3-study-pexidartinib-met-primary-endpoint-tgct/ 2017-10-31T07:18:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/bayers-bay94-9027-biologics-license-application-accepted-u-s-fda/ 2017-10-31T07:22:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/incyte-astrazeneca-enter-clinical-trial-collaboration-early-lung-cancer/ 2017-10-31T07:29:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/cmp-pharmas-carospir-now-available/ 2017-10-31T07:36:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/CaroSpir-Spironolactone.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/CaroSpir-Spironolactone.jpg http://www.pharmajournalist.com/mustang-bio-establishes-car-t-cell-therapy-manufacturing-facility-massachusetts/ 2017-10-31T07:40:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/mustang-bio-logo.jpg http://www.pharmajournalist.com/daiichi-sankyo-glycotope-enter-strategic-adc-alliance/ 2017-10-31T07:46:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/novartis-announces-planned-acquisition-advanced-accelerator-applications/ 2017-10-31T07:50:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/recipharm-equips-lisbon-facility-us-european-serialisation/ 2017-10-31T08:08:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/astrazeneca-selects-dnanexuss-cloud-based-platform-cgr/ 2017-10-31T08:10:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/bormioli-rocco-pharma-strengthens-service-north-american-market/ 2017-10-31T08:15:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Bormioli-Rocco-Pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/Bormioli-Rocco-Pharma.jpg http://www.pharmajournalist.com/tubilux-selects-tracelink-achieve-eu-fmd-compliance/ 2017-10-31T08:18:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/tracelink-logo.png http://www.pharmajournalist.com/pilgrim-introduces-oos-management-software-support-pharmaceutical-manufacturing-2/ 2017-10-31T08:22:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/pilgrim-logo.png http://www.pharmajournalist.com/werum-solutions-launches-standalone-version-pas-x-kpi-software/ 2017-10-31T08:25:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Werum-IT-Solutions-Gmbh.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/Werum-IT-Solutions-Gmbh.jpg http://www.pharmajournalist.com/parallel-trade-pharma-opportunities-challenges-ahead-beyond-brexit-registration-now-open/ 2017-10-31T09:29:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/introducing-smis-12th-annual-paediatric-clinical-trials-conference-featuring-new-mhra-regulatory-keynote-2018/ 2017-10-31T09:33:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/smis-pharma-usa-week-attendee-list-released-ahead-pharmaceutical-microbiology-east-coast-2017/ 2017-10-31T13:41:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/smi-usa-pharma-week-providing-platform-shared-expertise-intelligent-discussions/ 2017-10-31T13:46:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/impel-neuropharma-announces-first-patient-dosed-phase-1-clinical-trial-inp104/ 2017-11-01T09:50:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/impel-neuropharma-logo.png http://www.pharmajournalist.com/milliporesigma-samsung-biologics-extend-strategic-alliance/ 2017-11-01T09:57:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/MilliporeSigma-Samsung-MoU.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/MilliporeSigma-Samsung-MoU.jpg http://www.pharmajournalist.com/medicure-acquires-license-sell-market-prexxartan-u-s-carmel/ 2017-11-01T10:04:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/medicure-inc-logo.gif http://www.pharmajournalist.com/fda-approves-astrazenecas-calquence-treatment-adult-patients-mcl/ 2017-11-01T10:14:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/abbott-announces-fda-clearance-alinity-ci-series-diagnostic-systems/ 2017-11-01T10:21:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Abbott1.png http://www.pharmajournalist.com/ppd-awarded-nih-contract-clinical-research-support-services/ 2017-11-01T10:25:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/aviragen-therapeutics-vaxart-enter-merger-agreement/ 2017-11-01T10:30:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/aviragen-logo.jpg http://www.pharmajournalist.com/teva-announces-completion-paragard-divestiture-coopersurgical/ 2017-11-02T10:07:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/normon-selects-tracelink-comply-eu-fmd-serialization-regulations/ 2017-11-02T10:15:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/tracelink-logo.png http://www.pharmajournalist.com/redhill-biopharma-intelgenx-submits-nda-fda-rizaport-migraines/ 2017-11-02T10:27:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/redhill-biopharma-logo.png http://www.pharmajournalist.com/almac-group-announces-acquisition-bioclin-laboratories/ 2017-11-02T10:29:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/bioclin-lab-logo.png http://www.pharmajournalist.com/fda-grants-fast-track-designation-visterras-vis410/ 2017-11-02T10:31:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/astrazeneca-provides-update-tralokinumab-phase-iii-programme-severe-uncontrolled-asthma/ 2017-11-02T10:36:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/preliminary-attendee-list-announced-pre-filled-syringes-europe-2018/ 2017-11-06T12:38:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/otsuka-announces-phase-3-results-tolvaptan-patients-adpkd/ 2017-11-06T14:19:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/otsuka-europe.jpg http://www.pharmajournalist.com/merck-cdrd-announce-joint-investment-canadian-life-sciences-ecosystem/ 2017-11-06T14:20:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/boehringer-ingelheim-dicerna-develop-novel-treatments-chronic-liver-diseases/ 2017-11-06T14:22:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/wuxi-biologics-pall-corporation-establish-joint-continuous-bioprocess-laboratory/ 2017-11-06T14:24:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/stealth-biotherapeutics-initiates-phase-3-study-elamipretide-patients-pmm/ 2017-11-06T14:35:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/stealth-biotherapeutics-logo.png http://www.pharmajournalist.com/stelara-ustekinumab-shows-positive-results-treatment-lupus-phase-2-trial/ 2017-11-06T14:38:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/artemis-therapeutics-receives-orphan-drug-designation-fda-artemisone/ 2017-11-06T14:43:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/artemis-therapeutics-logo.jpg http://www.pharmajournalist.com/abbotts-mitraclip-device-approved-treatment-people-mitral-regurgitation/ 2017-11-06T14:51:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Abbott1.png http://www.pharmajournalist.com/ec-approves-novartiss-rydapt-two-indications-rare-hard-treat-cancers/ 2017-11-06T15:53:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/always-fight-can-parallel-distribution-industry-work-together/ 2017-11-07T06:38:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/fujifilm-expands-biopharmaceutical-contract-development-manufacturing-business/ 2017-11-07T13:38:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Fujifilm-biopharmaceuticals.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/Fujifilm-biopharmaceuticals.jpg http://www.pharmajournalist.com/therapeuticsmd-announces-plan-resubmit-new-drug-application-tx-004hr/ 2017-11-07T13:41:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/therapeuticsmd_logo.png http://www.pharmajournalist.com/pharmamar-announces-licensing-agreement-boryung-pharm-zepsyre-korea/ 2017-11-07T13:47:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/pharmamar1.jpg http://www.pharmajournalist.com/fda-approves-first-treatment-certain-patients-ecd-rare-blood-cancer/ 2017-11-08T13:14:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/almirall-opts-werums-pas-x-manufacturing-execution-system/ 2017-11-08T13:37:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Almirall_Plant_Reinbek.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/Almirall_Plant_Reinbek.jpg http://www.pharmajournalist.com/millendo-therapeutics-announces-positive-topline-phase-2-results-atr-101-classic-cah/ 2017-11-08T13:40:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/millendo-therapeutics-logo1.jpg http://www.pharmajournalist.com/clinical-trial-finds-blood-plasma-infusions-alzheimers-safe-promising/ 2017-11-08T13:48:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Sharon-Sha.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/11/Sharon-Sha.jpg http://www.pharmajournalist.com/valeant-agrees-sell-sprout-former-shareholders-sprout-pharmaceuticals/ 2017-11-08T13:53:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/valeant-pharma.jpg http://www.pharmajournalist.com/torrent-acquire-branded-business-india-nepal-unichem/ 2017-11-08T13:56:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/torrent-pharmalogo.png http://www.pharmajournalist.com/neurimmune-collaborates-ono-pharma-neurodegenerative-diseases-field/ 2017-11-09T13:14:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/neurimmune-image.jpg http://www.pharmajournalist.com/boehringer-mina-develop-novel-treatment-approaches-fibrotic-liver-diseases/ 2017-11-09T13:16:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/uk-drug-developer-rxcelerate-opens-first-us-base-boston/ 2017-11-09T13:53:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/RxCelerate-Boston.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/RxCelerate-Boston.jpg http://www.pharmajournalist.com/cambrex-invests-new-small-scale-capacity-charles-city-iowa-facility/ 2017-11-09T14:01:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/cambrex.jpeg https://pharmajournalist.com/wp-content/uploads/2017/11/cambrex.jpeg http://www.pharmajournalist.com/spark-therapeutics-pfizer-amend-license-agreement-spk-9001/ 2017-11-09T14:09:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/spark-therapeutics.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/11/spark-therapeutics.jpg http://www.pharmajournalist.com/innovus-pharma-announces-agreement-acon-laboratories/ 2017-11-10T15:15:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/innovus-pharma-office.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/innovus-pharma-office.jpg http://www.pharmajournalist.com/ionis-licenses-novel-antisense-drug-treatment-cnm-dynacure/ 2017-11-10T15:18:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/ionis-pharma.jpg http://www.pharmajournalist.com/alcami-announces-manufacturing-agreement-solasias-api-darinaparsin/ 2017-11-10T15:24:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/alcami-logo.jpg http://www.pharmajournalist.com/vetter-expands-footprint-asia-pacific-region/ 2017-11-10T15:31:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Asia-Pacific-Vetter-1.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/Asia-Pacific-Vetter.jpg http://www.pharmajournalist.com/biomatrix-family-companies-expands-acquisition-elwyn-pharmacy-group/ 2017-11-10T15:40:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/BioMatrix-logo.jpg http://www.pharmajournalist.com/signet-accel-announces-curt-weber-national-sales-director-pharma-division/ 2017-11-10T15:55:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Curt-Weber-Signet-Accel.png http://www.pharmajournalist.com/wp-content/uploads/2017/11/Curt-Weber-Signet-Accel.png http://www.pharmajournalist.com/sanofi-principia-agree-develop-multiple-sclerosis-drug-candidate/ 2017-11-10T16:01:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/splunk-machine-learning-helps-recursion-pharmaceuticals-treat-genetic-diseases/ 2017-11-10T16:19:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/splunk-logo.jpg http://www.pharmajournalist.com/intellectual-property-regulatory-law-recent-developments-parallel-trade-2018/ 2017-11-13T09:02:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/create-integrated-social-media-digital-strategy-patients-effective-content/ 2017-11-13T09:06:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/healthcare-meets-technology-future-ready-medical-innovations-12th-edition-medical-fair-asia/ 2017-11-13T09:23:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Medical-Fair-Asia-Press-Photo-PJ.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/11/Medical-Fair-Asia-Press-Photo-PJ.jpg http://www.pharmajournalist.com/smi-group-exclusive-speaker-interview-professor-nagy-habib-mina-therapeuticsimperial-college-london/ 2017-11-13T13:06:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/pre-filled-syringes-increased-focus-safety-human-centred-approaches/ 2017-11-13T13:11:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/zymeworks-announces-license-agreement-johnson-johnson-innovation/ 2017-11-14T14:12:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/zymeworks.jpeg http://www.pharmajournalist.com/avista-pharma-solutions-doubles-api-manufacturing-capacity-colorado-facility/ 2017-11-14T14:15:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Avista-Pharma-Solutions.jpg http://www.pharmajournalist.com/excision-biotherapeutics-secures-license-uc-berkeley-crispr-gene-editors/ 2017-11-14T14:21:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/excision-logo.jpg http://www.pharmajournalist.com/absorption-systems-acquires-tga-sciences-based-medford-ma/ 2017-11-14T14:25:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Absorption-Systems-logo.png http://www.pharmajournalist.com/allergan-receives-fda-approval-use-vraylar-cariprazine/ 2017-11-14T14:28:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/theravance-biopharma-mylan-submits-nda-fda-revefenacin-td-4208/ 2017-11-14T14:31:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-1.jpg http://www.pharmajournalist.com/evonik-launches-new-sterile-ultra-low-metal-content-bioresorbable-polymers/ 2017-11-14T14:36:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Evonik.jpg http://www.pharmajournalist.com/abbvie-astrazeneca-present-keynote-address-smis-drug-discovery-2018/ 2017-11-15T12:30:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/arvinas-expands-strategic-license-agreement-genentech/ 2017-11-16T15:26:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Arvinas-llc.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/Arvinas-llc.jpg http://www.pharmajournalist.com/ascentage-announces-fda-acceptance-ind-application-novel-iap-inhibitor-apg-1387/ 2017-11-16T15:29:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/bristol-myers-squibb-syngene-international-expand-ongoing-research-collaboration/ 2017-11-16T15:31:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/alcami-furthers-expansion-new-west-coast-sales-office/ 2017-11-16T15:39:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/alcami-corporation.jpg http://www.pharmajournalist.com/insulia-receives-fda-clearance-ce-mark-integrate-basaglar-tresiba/ 2017-11-16T15:47:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Insulia-app.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/Insulia-app.jpg http://www.pharmajournalist.com/purdue-pharma-announces-strategic-investment-oncology-rd/ 2017-11-16T15:49:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/purdue-pharma.jpg http://www.pharmajournalist.com/roche-launches-discovery-teal-hrp-kit-advance-tissue-based-cancer-research/ 2017-11-16T15:50:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/roche.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/roche.jpg http://www.pharmajournalist.com/doctors-conversations-differ-private-public-social-networks-social-media-pharma/ 2017-11-20T06:40:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/peptidream-announces-discovery-collaboration-agreement-bayer/ 2017-11-21T05:56:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/wuxi-apptec-selected-iqvia-stem-cell-center-serve-gmp-manufacturer-advanced-therapies/ 2017-11-21T06:00:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-apptec-logo.png http://www.pharmajournalist.com/fda-approves-kaleos-auvi-q-epinephrine-injection-usp-0-1-mg-auto-injector/ 2017-11-21T06:05:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/tesaro-announces-european-commission-approval-zejula-women-recurrent-ovarian-cancer/ 2017-11-21T06:08:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/tesaro-inc-logo1.jpg http://www.pharmajournalist.com/cue-biopharma-announces-strategic-research-collaboration-license-agreement-merck/ 2017-11-21T06:12:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/faslodex-receives-fda-approval-treatment-advanced-breast-cancer-combination-abemaciclib/ 2017-11-21T06:14:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/revance-announces-orphan-drug-designation-rt002-treatment-cervical-dystonia/ 2017-11-21T06:18:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/revance-logo.jpg http://www.pharmajournalist.com/aveo-oncology-appoints-nikil-mehta-svp-regulatory-quality-assurance/ 2017-11-21T06:23:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/aveo-oncology1.jpg http://www.pharmajournalist.com/samsung-bioepis-receives-regulatory-approval-trastuzumab-biosimilar-ontruzant/ 2017-11-21T06:29:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Samsung-Bioepis.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/Samsung-Bioepis.jpg http://www.pharmajournalist.com/cerecor-acquires-trx-pharmaceuticals/ 2017-11-21T06:33:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/cerecor-inc-logo.png http://www.pharmajournalist.com/ionis-pharmaceuticals-licenses-second-orally-delivered-antisense-drug-janssen/ 2017-11-21T06:35:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/novartis-ascp-acs-join-forces-fight-cancer-ethiopia-uganda-tanzania/ 2017-11-21T06:39:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/zubsolv-receives-authorization-treatment-opioid-dependence-europe/ 2017-11-21T14:06:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/superbugs-exclusive-interviews-released-abac-therapeutics-alchemy-biomedical-oppilotech/ 2017-11-22T16:08:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/agenda-released-smi-groups-adaptive-designs-clinical-trials-2018/ 2017-11-23T12:51:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/reykhorland-vice-president-business-development-tissuse-gmbh-discuss-multi-organ-chip-technologies-drug-discovery-2018/ 2017-11-23T14:38:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/proteome-sciences-plc-announce-good-clinical-laboratory-practice-accreditation/ 2017-11-24T12:40:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Proteome_Logo.jpg http://www.pharmajournalist.com/kmt-hepatech-announces-strategic-investment-phoenixbio/ 2017-11-24T12:48:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/KMT-Hepatech-logo.jpg http://www.pharmajournalist.com/fresenius-kabi-expand-pharmaceutical-manufacturing-north-carolina/ 2017-11-24T12:51:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Fresenius-Kabi.jpg https://pharmajournalist.com/wp-content/uploads/2017/11/Fresenius-Kabi.jpg http://www.pharmajournalist.com/systech-international-nkp-pharma-partner-expand-presence-india/ 2017-11-24T12:58:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/systech-international-logo.jpg http://www.pharmajournalist.com/marimed-expands-maryland-opening-cannabis-cultivation-facility-hagerstown/ 2017-11-24T13:01:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/marimed-logo.jpg http://www.pharmajournalist.com/beactica-awarded-funding-develop-new-therapeutics-aggressive-brain-tumours/ 2017-11-24T13:06:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/beactica-logo.jpg http://www.pharmajournalist.com/lead-pharma-sanofi-collaboration-autoimmune-diseases-achieves-third-milestone/ 2017-11-24T13:09:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/discover-future-social-pharma-social-media-pharmaceutical-industry/ 2017-11-27T05:54:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/stealth-biotherapeutics-granted-fast-track-designation-treatment-barth-syndrome/ 2017-11-28T08:24:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/stealth-biotherapeutics-logo.png http://www.pharmajournalist.com/catalyst-pharmaceuticals-achieves-positive-results-second-phase-3-clinical-trial/ 2017-11-28T08:27:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/recipharm-equips-three-facilities-us-serialisation/ 2017-11-28T08:29:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/brammer-bio-launches-gene-therapy-product-manufacturing-operations-massachusetts/ 2017-11-28T08:33:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Brammer-Bio.png https://pharmajournalist.com/wp-content/uploads/2017/11/Brammer-Bio.png http://www.pharmajournalist.com/hitgen-boehringer-enter-dna-encoded-library-based-drug-discovery-research-collaboration/ 2017-11-29T06:15:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/pharming-submits-application-fda-ruconest-treat-hae/ 2017-11-29T06:29:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/pharming-group-nv.jpg http://www.pharmajournalist.com/takeda-initiates-phase-1-clinical-trial-zika-vaccine-candidate/ 2017-11-29T06:33:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/astrazeneca-submits-snda-tagrisso-1st-line-egfrm-nsclc-japan/ 2017-11-29T06:41:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/biogen-alkermes-collaborates-develop-commercialize-alks-8700/ 2017-11-29T07:01:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/sobi-receives-approval-orfadin-nitisinone-oral-suspension-treatment-ht-1/ 2017-11-29T07:04:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/sobi.jpg http://www.pharmajournalist.com/fda-renews-expands-portfolio-simcyp-simulator-pbpk-licenses/ 2017-11-29T07:06:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/biocad-launches-new-manufacturing-site-north-africa/ 2017-11-30T10:18:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/biocad-logo.jpg http://www.pharmajournalist.com/titan-pharmaceuticals-partners-molteni-market-probuphine-europe/ 2017-11-30T10:20:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TITAN-Pharma-logo.png http://www.pharmajournalist.com/gsk-submits-us-regulatory-application-single-dose-tafenoquine-p-vivax-malaria/ 2017-11-30T10:27:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/andrew-hopkins-chief-executive-exscientia-discuss-role-artificial-intelligence-small-molecule-drug-discovery/ 2017-11-30T10:30:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/new-confirmed-delegates-speakers-rna-therapeutics/ 2017-12-06T07:46:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/sunovion-receives-fda-approval-lonhala-magnair-inhalation-solution-treat-copd/ 2017-12-06T10:52:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sunovion-logo.jpg http://www.pharmajournalist.com/mylan-aspen-announce-launch-generic-busulfex-injection/ 2017-12-06T10:53:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan.jpg http://www.pharmajournalist.com/first-patient-enrolled-phase-3-trial-atir101-adult-patients-blood-cancer/ 2017-12-06T10:55:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/pfizer-develop-commercialize-cresemba-china-asia-pacific-region/ 2017-12-06T11:02:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/ema-accepts-marketing-application-trastuzumab-pegfilgrastim/ 2017-12-06T11:07:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan.jpg http://www.pharmajournalist.com/lilly-initiates-clinical-trial-evaluate-functionality-safety-aid-system/ 2017-12-06T11:13:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-grants-genentechs-avastin-full-approval-aggressive-form-brain-cancer/ 2017-12-06T11:17:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/advanced-clinical-expands-operations-europe-two-new-offices/ 2017-12-07T14:19:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/advanced-clinical-logo.jpg http://www.pharmajournalist.com/carmot-enters-multi-year-drug-discovery-collaboration-amgen/ 2017-12-07T14:23:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/concentric-analgesics-receives-fda-fast-track-designation-ca-008-post-surgical-pain/ 2017-12-07T14:27:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/neon-therapeutics-announces-clinical-trial-collaboration-merck/ 2017-12-07T14:29:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/acorda-resubmits-new-drug-application-inbrija-cvt-301-levodopa-inhalation-powder/ 2017-12-07T14:49:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Acorda-Therapeutics-logo.jpg http://www.pharmajournalist.com/gilead-sciences-kite-acquire-cell-design-labs/ 2017-12-08T08:32:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gilead.jpg http://www.pharmajournalist.com/immuneed-shows-unique-immunomodulating-drug-safety-evaluation-assay-new-strategy-therapeutic-cancer-vaccination/ 2017-12-08T08:44:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Sara-Mangsbo.png https://pharmajournalist.com/wp-content/uploads/2017/12/Sara-Mangsbo.png